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 1.  
General introduction  
1.1. Relevance of the present work 
Population aging and the global burden of late-life diseases 
Only one century, i.e. from 1850 to 1950, was needed for humans to double their life expectancy 
[1] (Figure 1.1). Much of this dramatic increase in life expectancy can be explained by lower 
early life mortality after improvements in the quality of water, food, hygiene, housing, and 
medical care [2]. In this millennium (from 2000 to 2016), life expectancy has only risen 4.76 ± 
1.12 years so far (life expectancy nowadays is ~77 years in developed countries; see 
http://apps.who.int/gho/data/view.main.SDG2016LEXREGv?lang=en; accessed 03.2019).  
 
 
Figure 1.1. World life expectancy estimates compared, 1800 - 2001 (modified from [3]). HDR 
= UNDP, Human Development Report, various years; WDI = World Bank, World 
Development Indicators 2004. SOURCES: World Bank 2004; United Nations Development 
Programme (various years); United Nations 1995, 1998; Siampos 1989, who on p. 424 
reproduces without reference what may be a League of Nations or UN estimate for 1930; United 
Nations 1975a: 1; 1975b, I: 175; and 1988 
 
However, living longer does not necessarily mean that the years gained are characterized by 
health and reproductivity [4]. Infectious diseases do no longer represent leading causes of death 
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in developed populations, but they have been replaced by chronic degenerative diseases like 
cancer and cardiovascular diseases that occur later in life (a phenomenon known as 
"epidemiologic transition" [5]. While the shift from early mortality by infectious diseases to 
long lives with chronic diseases was triggered, as aforementioned, by improved lifestyle 
(hygiene) and medical conditions (vaccines, antibiotics), curing degenerative diseases 
nowadays is still hindered by knowledge gaps concerning the mechanisms of aging [6, 7]. It is 
well accepted that aging, the progressive accumulation of molecular damage and consequential 
loss of biological functioning, is the most important risk factor for chronic diseases and drives 
both morbidity and mortality [8]. 
 
The proportion of elderly is increasing and an alarming 16-20% of the late life is spent in 
morbidity, partly because medical treatments allow diseased people to survive longer with their 
illness [9, 10]. Late-life diseases become a global burden with vast economic implications [7]. 
If or how long the increase in life expectancy will continue or if there is a limit to human lifespan 
is lively debated among scientists [6, 11]. Some researchers even foresee a reversal, i.e. an 
eventual decrease in life expectancy [12]. 
 
One focus of modern aging research is on how to compress the morbid phase at the end of life 
(see e.g. [13]). Both aging and longevity have a genetic contribution, and both are also vastly 
influenced by environmental factors [14, 15]. Obviously, long-lived individuals (LLI) are also 
aged and show the common signs of aging (e.g. wrinkles, grey hair). The likelihood of a long 
lifespan, i.e. of becoming long-lived, is limited by individual aging processes. It becomes clear 
that aging and longevity are different phenotypes, but highly connected. In the past, both studies 
using (genetically modifiable) model organisms and research on LLI have helped shed light on 
genes and pathways responsible for or contributing to (healthy) aging and longevity. 
 
1.2. Aging and longevity in model organisms 
Aging can be defined as a progressive functional decline of an organism with  a gradual 
deterioration of physiological function, including a decrease in fecundity [16, 17]. Sometimes, 
“aging” and “senescence” are used synonymously; however, the latter term rather refers to 
processes in a single cell [18]. 
 
The aging process, particularly in metazoans, appears to derive from intrinsic cellular 
mechanisms acting in parallel with changes in tissues. Scientists hypothesize that bone marrow 
3 
 
stem cells are crucial in the aging process due to their high self-renewal capacity [19]. Others, 
however, state that aging is controlled by a specific tissue or organ (e.g., the hypothalamus) 
rather than single cell populations [20–22]. Yet, despite the complexity of the aging processes, 
there is no scientific basis for the notion that aging is an inevitable process that cannot be 
stopped or postponed [23]. Many aging and longevity-associated pathways are evolutionarily 
highly conserved. Therefore, studies in model organisms, including yeast, nematodes, fruit 
flies, and mice, help shed light on those processes. Despite the yet not fully resolved aging 
mechanisms, it has been demonstrated in model organisms that lifespan can be extended to 
some degree. For example, mutations in genes associated with the insulin/insulin-like signaling 
pathway (such as daf-2, daf-12, daf-16, or PI3KCS) in the nematode Caenorhabditis elegans (C. 
elegans) extended the lifespan of the organisms nearly 10-fold [24]. In mice, over-expression 
of the klotho gene which acts as a circulating hormone extended lifespan by ~30% [25], and 
disruption of the growth hormone receptor extended lifespan by more than 40% [26]. 
Furthermore, mice with mutations in Prop1 (a transcription factor that regulates Pit1, a gene 
related to the insulin/insulin-like signaling pathway) lived twice as long as control mice that 
did not carry the mutation [27]. 
 
Caloric restriction (CR), i.e. reduced energy intake without malnutrition, appears to be the only 
lifestyle intervention so far that has led to increased lifespan in various lower model organisms, 
e.g. in C. elegans and in the fruit fly Drosophila melanogaster (D. melanogaster). Studies have 
also shown beneficial effects of CR on survival and health in mammals like mice and rhesus 
monkeys [28–30], and very recently, CR led to improved health measures (e.g. reduction of 
oxidative damage) in healthy non-obese humans [31]. 
 
1.2.1. The potentially immortal freshwater polyp Hydra vulgaris 
Along the evolutionary tree, diverse forms of aging appear which are reflected in wide 
differences in lifespan. For example, some species of reptiles, amphibians, fishes and birds 
appear to be able to delay age-related pathologies, maybe even the aging process itself [32]. 
Others, like the freshwater polyp Hydra (Figure 1.2), display negligible senescence or even 
escape the aging process by coupling vegetative propagation to sexual reproduction [33, 34]. 
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Figure 1.2. The freshwater polyp Hydra in its completely differentiated form (modified from 
[35]). 
 
Hydra is considered to be potentially immortal. Impressively, when gametogenesis is induced 
in Hydra (e.g., H. oligactis or Pelmatohydra robusta), aging patters seem to emerge which lead 
to the death of the organism within 100 to 120 days [34]. Gametogenesis in Hydra was shown 
to be associated with loss of interstitial stem cells and their somatic derivatives [34]. This 
pattern resembles the humans aging process which is related to the reduction of the capacity of 
self-renewal due to loss of somatic stem cells [36, 37]. Therefore, Hydra’s immortality was 
initially thought to be due to its asexual mode of reproduction. However, nowadays, it is widely 
accepted that the self-renewal capacity of the stem cell lineages contributes significantly to 
Hydra´s immortality, and one of the genes correlated with this capacity is the forkhead box O 
(FoxO) gene [38]. FoxO is an evolutionarily conserved transcription factor with a well-known 
role in cellular responses to environmental and physiological stress [39], and has been validated 
as a central regulator of lifespan across species [40]. In H. vulgaris, FoxO correlated with stem 
cell proliferation, budding processes and continuous self-renewal capacity [38]. Additionally, 
FoxO was shown to be crucial for the functional maintenance of the innate immune system and 
immune peptides production [35, 41]. Experimental evidence from studies in flies, worms and 
mice indicated that FoxO extends lifespan by stimulating cell survival, stem cell control, and 
tissue homeostasis [39, 40]. Strikingly, specific mutations in the human FOXO3 gene 
predispose to human longevity [42–44]. 
 
In addition to Hydra's immortality status, its potential as a model organism for aging and 
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longevity studies is remarkable. Studies focusing on the identification of orthologous genes 
among species showed that Hydra shares at least 6,071 genes with humans [45]. Impressively, 
of 259 human aging genes, 207 (80%) were shared by Hydra. In contrast, some of the human 
aging genes shared by Hydra were missing or poorly conserved in D. melanogaster and C. 
elegans (e.g., MDM2 or TGFβ inhibitor noggin) [46]. This evidence, along with the unique 
experimental techniques (e.g., genomics, transcriptomics, and transgenics), published in 
previous studies, highlights Hydra as a powerful model for mechanistic aging studies [46, 47].  
 
Studying aging processes in other animals and comparing the way different species age or 
escape aging, helps scientists to gather knowledge about human aging and may eventually yield 
clues on how to delay it. In summary, research in animal models and humans has shown that 
genetic and environmental factors affect both life- and healthspan and both can potentially be 
prolonged. 
 
1.3. Human longevity 
Longevity could be defined as the period of time an organism is expected to live under ideal 
circumstances. Evolutionary and genetic research indicates that longevity has been a by-product 
of evolution, and results from the integration of many genetic and environmental factors which 
furthermore interact with each other; therefore, longevity can be considered as a complex trait 
[16, 17, 48, 49]. 
 
1.3.1. The genetics of human longevity 
Hundreds of genes have been identified to be capable of influencing longevity [50]; most of 
them can be allocated to one or more of the following pathways i) protein homeostasis, ii) 
insulin/insulin-like growth factor signaling (IIS), iii) mitochondrial metabolism, iv) sirtuin 
signaling, v) chemosensory function or vi) pathways associated with CR [51, 52]. This aging 
gene pool was predominantly defined with the help of model organisms (e.g., Saccharomyces 
cerevisiae (S. cerevisiae), C. elegans and D. melanogaster) using experimental approaches such 
as random mutagenesis [53] or overexpression screenings [54, 55]. However, aforementioned 
techniques are suitable for models that are relatively simple and inexpensive to maintain in the 
laboratory (e.g., Hydra), but not for long-lived models and/or those less flexible to targeted 
genetics (e.g., humans). In humans, genetic mapping techniques, either by studying a secondary 
phenotype that correlates with longevity (e.g., for humans: Hutchinson–Gilford progeria, 
mandibuloacral dysplasia, Werner’s syndrome) [15], or the investigation of a genetically 
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diverse population with a natural variation in lifespan allow scientists to identify longevity-
associated loci [14]. 
 
 
Figure 1.3. Proportion of individuals reaching extreme ages either by surviving, delaying or 
escaping morbidity in three age groups: centenarians (100-104years), semisupercentenarians 
(105-109 years) and supercentenarians (110+ years) [56]. “Survivors” refers to individuals with 
at least one disease with an onset of prior to age 80 years; “delayers”, at least one disease with 
an onset between age 80 and 90 years; escapers, at least one disease with an onset after age 100 
years [56]. 
 
Epidemiological and demographical analyses indicate that natural variation in human longevity 
is diverse [57, 58]. While some studies showed that centenarians escape major diseases [59], 
other reports indicated that centenarians often suffer from multi-morbidity [57, 60, 61]. Hence, 
it has been suggested that humans can reach extreme ages either by surviving, delaying or 
escaping morbidity (Figure 1.3) [56, 58]. This indicates that there are multiple ways to achieve 
exceptional longevity which has implications on both the way how contrasting populations 
(case-control cohorts) are defined and on the approaches used to identify genetic variants that 
affect this trait, e.g., longitudinal, cross-sectional, genetic linkage, and association-based 
studies. Additionally, the genetic contribution to longevity was shown to increase with age; 
therefore, individuals with 100 years of age or older are likely to be the most informative 
subjects for investigating the genetics of human longevity [14]. 
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Longitudinal studies in humans would represent the gold standard in human longevity research 
[62, 63]; however, securing the budget and retention of the participants within a long-term study 
are two major problems generally encountered with a longitudinal study design. Longitudinal 
longevity studies specifically are further hampered by the fact that the proportion of individuals 
that will reach exceptional longevity is too small to conduct statistically meaningful analyses 
[64]. Alternatively, genetic linkage (a family-based approach) and population-based association 
analyses have been largely employed in human longevity research [64]. 
 
Linkage analysis is a technique which is based on the fact that genes or DNA segments that are 
physically close to each other tend to be inherited together. For any trait with a genetic 
contribution, this enables the identification of chromosomal regions that co-segregate among 
affected family members using polymorphic markers that are evenly distributed throughout the 
genome [65]. In longevity research, linkage studies conducted on twins yielded the estimates 
for the longevity heritability in humans which was found to be rather modest, i.e. between 20% 
and 30% [66–68]. Additionally, with relative large sample sizes, at least ten longevity loci 
(3p22, 4q22-25, 8q23, 9q31-34, 12q24, 14q11, 17q12-q21, 17q22, 18q23-24, and 19p13) were 
identified by applying this study design [69–71]. 
 
Mutations in the genome can contribute to an increased or reduced disease or phenotype risk in 
a population. Genome-wide association studies (GWAS) help to identify mutations related to 
the phenotype of interest. The most commonly used type is the case-control study design, in 
which frequencies of genetic markers (e.g., single nucleotide polymorphisms (SNPs)) are 
compared between contrasting populations, e.g., healthy (controls) and sick (cases) individuals, 
to identify SNPs that significantly differ in frequency. Longevity GWAS can be divided into 
two major types depending on the evaluated phenotype. In the first (traditional) type, the 
genotype of each individual is determined and correlated with the phenotype of the individual 
itself. The second type focuses on parental longevity and evaluates the genotype of each 
individual correlated with the age or phenotype of the parents. 
 
Since longevity-associated variants have barely reached genome-wide significance (GWS; P-
value < 5 x 10E-08), longevity is thought to depend on small-effect alleles [72–75]. Yashin et 
al. [76] genotyped 1,173 individuals and analyzed 169 putative SNPs for an association with 
longevity (P-value < 1 x 10E-06). They demonstrated a significant and substantial joint 
influence of small-effect alleles on human lifespan. This finding has two major implications: 
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First, a relaxation of the GWS threshold in longevity is needed to identify the right trade-off 
between false-positive and biologically relevant signals; in other words, statistics needs to be 
adapted to the biological problem. As discussed later, this would also contribute to solving the 
so-called ‘‘missing-heritability problem’’ [77]. Second, complex traits like longevity might 
exhibit a non-additive (nonlinear) joint genetic influence (epistasis). Therefore, it has been 
proposed to analyze small-effect alleles, the so-called omnigenic model [78]. In this model it is 
taken into account that association signals tend to be spread across the genome and may include 
genes without an obvious connection to the trait under study. The omnigenic model 
differentiates between core and peripheral genes and accounts for the effect size of the genetic 
variants. The core genes are those which harbor mutations with strong effects (normally 
reaching GWS) and a biologically interpretable role in the trait studied. The peripheral genes 
include all genes with apparently no relevant effects on the trait (fail reaching GWS). Longevity 
likely is a result of many processes involving core genes such as FOXO3 [42, 43, 79] and 
apolipoprotein E (APOE) [72, 80, 81] as well as other loci with only a suggestive association 
with longevity (P-value < 5 x 10E-06). 
 
The first longevity association dates back to the 1990s. Back then, the ɛ4 allele in the 
apolipoprotein E (APOE) gene was reported to be negatively associated with human longevity 
[80]. This finding derived from a candidate gene association study (CGAS), in which 
associations of variants in pre-defined loci with a trait, e.g., longevity, are investigated. APOE 
plays an important role in lipid metabolism in both peripheral tissues and the brain. The 
deleterious ɛ4 allele is associated with an increased risk and an earlier onset of various chronic 
degenerative diseases, like cardiovascular and Alzheimer’s disease [72, 80, 81]. Up to now, the 
negative longevity association of APOE ɛ4 has been confirmed in various populations. 
 
In 2008, the FOXO3-longevity association was published; first reported in Japanese-Americans 
[42], and later confirmed in other populations including Germans [43, 82, 83]. The protein 
FOXO3 is a key player in the IIS pathway [39, 52]. Activation of IIS correlates inversely with 
the expression of FOXO3 and its targets, as upon IIS activation FOXO3 is phosphorylated and 
excluded from the nucleus. In contrast, oxidative stress activates FOXO3 by inducing its 
dephosphorylation and translocation to the nucleus where FOXO3, in its function as a 
transcription factor, enhances the transcription of stress-response genes, which aid in cell 
protection and maintenance. Increased FOXO3 expression led to lifespan extension in Hydra, 
C. elegans and D. melanogaster [52, 84]. Many non-coding FOXO3-variants have been shown 
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to be associated with human longevity [74]. Some of them have already been analyzed in more 
depth with regard to functional implications and/or phenotypic associations. For example, the 
longevity-associated G allele of rs2802292 was reported to be associated with a higher 
peripheral and hepatic insulin sensitivity and increased FOXO3 expression in skeletal muscle 
[85]. The minor allele (G) of rs12212067 was associated with an anti-inflammatory role [86] 
which was reflected in lower "inflammaging" in LLI [87]. In a recent study, the longevity-
associated minor alleles of rs12206094 (T) and rs4946935 (A) both showed considerable 
enhancer activities in luciferase activity assays that were reversed by IGF-1 treatment. This 
may indicate an allele-specific response to nutritional stress. In the same report, the longevity 
alleles of both SNPs were shown to be associated with increased FOXO3 expression in various 
tissues [44]. 
 
In order to extend the list of loci associated with human longevity, several large-scale meta-
analyses have been conducted. One of these included 14 different studies with individuals of 
European descent [81]. They identified a novel locus, chromosome 5q33.3 (rs2149954, P-value 
< 5 x 10E-08), to be associated with longevity. The T-allele of this single-nucleotide variant 
(SNV) had previously been reported to be associated with low blood pressure in middle age 
and to reduce the cardiovascular mortality risk (independent of the effects on blood pressure) 
[88, 89]. A meta-analysis on parental lifespan led to the discovery of two more regions: HLA-
DQA1/DRB1 (rs34831921) and LPA (rs55730499) [86]. Furthermore, in that study, previous 
longevity-associated loci were validated, i.e. CHRNA3/5 (rs8042849), CDKN2A/B (rs1333049, 
rs4977756) and SH2B3 (rs3184504) [90]. A disease-informed GWAS, in which knowledge 
from large studies of age-related diseases was integrated to narrow down the potential gene 
pool of longevity, identified genetic loci associated with exceptional human longevity including 
APOE, CDKN2B/ANRIL, ABO (tags the O blood group), and SH2B3/ATXN2 [91]. This study 
also substantiated the genetic overlap between longevity and age-related diseases [92]. 
 
Despite the long time that has passed since the initial findings and the suggestive variants that 
have been discovered, up to now, only a handful variants have remained with a confirmed 
longevity association across populations: Next to APOE and FOXO3, this includes the locus on 
chromosome 5 (chromosome 5q33.3), and the variants in CDKN2B. 
 
Despite the power of GWAS for the identification of new susceptibility loci, in longevity, the 
meta-analyses barely yielded novel genetic findings or overlap between studies. This 
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phenomenon has been partially attributed to inconsistent phenotype definitions across studies 
(especially with regard to the controls) [14, 93]. In addition, the individual longevity variants 
showed only weak effects which cannot reach GWS. Another surprising outcome from GWAS 
on complex traits was that GWAS-detected trait-associated SNVs explained only a small 
proportion of the total heritability (on average 5-10%). Furthermore, over 90% of the identified 
variants are located in non-coding regions, e.g., intronic or intergenic regions [14, 94–96]; this 
fact makes functional interpretations of GWAS findings highly challenging. 
 
Hitherto, GWAS efforts have been mostly focused on discovering common genetic variants 
based on the common disease-common variant (CD/CV) hypothesis. However, from an 
evolutionary perspective, it is more likely that rare mutations have larger effects on common 
diseases [97]. Joint influences of large-effect (rare) and weak-effect (common) variants might 
explain the genetic susceptibility to both common complex diseases/phenotypes [98] and late-
onset diseases. For example, the type 2 diabetes-associated loci MTNR1B was shown to harbor 
both rare and common variants [99]. Additionally, low-density lipoprotein levels were reported 
to be associated with common and rare variants in APOE and NPC1L1 [100, 101]. Likewise, 
variation in blood pressure was linked to rare and common variants in SLC12A3, SLC12A1, and 
KCNJ1 [102]. Also in Alzheimer´s disease, common and rare SNV-burden was detected in 
genes such as TREM2, CLU, SORL1, ABCA7, APP, PLD3, EPHA1, CR1, and BIN1 [103]. 
Recently, a whole-exome sequencing of 100 long-lived individuals (≥ 98 years) was performed 
to identify rare variants with large effects associated with extreme longevity [104]. 
Unfortunately, due to the limited sample size, no SNV reached statistical significance; however, 
the authors suggested LYST, MDN1, and RBMXL1, which showed nominal significance, to be 
genes that harbor an increased burden of rare variants. 
 
The evidence summarized above indicates that as a complex trait, longevity is very likely to be 
controlled by rare variants at many loci [105]; therefore extending the spectrum to rare 
susceptibility variants may help explain the missing heritability of longevity. 
 
1.4. The human gut microbiota in aging and longevity 
1.4.1. The human gut microbiota 
The gut microbiome (GM) is the complex collection of microorganisms that inhabit our 
gastrointestinal (GI) tract; according to initial estimates, approximately 1013 to 1014 
microorganisms reside inside the GI tract, exceeding the number of human cells in the body by 
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a factor ~10. Bacterial genes were reported to outnumber human genes even by a factor 100 
[106]. However, in a more recent report, the stated values are much lower, but still impressive 
(~1013 microorganisms, ratio human:microbial genes 1:1) [107]. In a balanced healthy state, the 
relationship between the human host and his gut microbes is symbiotic; therefore, humans are 
sometimes considered "meta-" or "superorganisms" [108, 109]. Indeed, the microbiota 
contributes to human health in multiple ways. As one of the key functions, it plays a pivotal 
role in the development of the immune system and in balancing pro- and anti-inflammatory 
responses. The metabolic capacity perfectly complements the human enzymatic repertoire, e.g. 
by facilitating energy harvest from otherwise indigestible fibers. Furthermore, it helps maintain 
the integrity of the gut barrier and protects the host from colonization by pathogenic 
microorganisms [109]. 
 
1.4.2. The human gut microbiota composition during development and in adulthood 
Aging is accompanied by changes in the gut microbiota composition. The colonization of the 
gut starts immediately after birth (or even already in utero), but microbial communities 
fluctuate particularly during the first three years of life until, after then, the structures stabilize 
to an adult-like status [110]. 
 
 
Figure 1.4. Gut microbiome changes from infancy to adulthood and factors influencing the 
microbial composition at the single stages ([111]). 
12 
 
 
Since the infant gut is initially an aerobic environment, facultative aerobe bacteria like 
Escherichia and Enterococcus, which derive from the mother and the environment, settle first. 
They induce a gradual change to more anaerobic conditions within a few days, which in turn 
allows a colonization by Firmicutes like Clostridia, Bacteroidetes, and Bifidobacteria [112]. 
During this process, the biodiversity of the GM increases in complexity and reaches a stable 
ecology structure at approximately three years of age [113]. Compared with the adult stage, 
childhood GM is still lower in microbial diversity, and characterized by both a low abundance 
of Bacteroidetes and higher abundances of Firmicutes and Actinobacteria. Species from the 
genus Bifidobacterium, the Lactobacillus group, and from the family Coriobacteraceae are also 
more abundant than in adulthood [114–116]. From a functional perspective, the childhood 
microbiota is characterized by an enrichment of genes that support growth, development, and 
production of vitamin B12 (124). In adulthood, the GM composition remains relatively stable. 
In healthy individuals, the dominating phyla are Firmicutes (families Lachnospiraceae and 
Ruminococcaceae), Bacteroidetes (Bacteroidaceae, Prevotellaceae, and Rikenellaceae), and 
Actinobacteria (Bifidobacteriaceae and Corinobacteriaceae). The families Lachnospiraceae 
(Eubacterium rectale group, 10 - 45%), Ruminococcaceae (Clostridium leptum group, 16 - 
27%), and Bacteroidaceae/Prevotellaceae (12 - 60%) together account for 60 - 90% of all the 
faecal bacteria [113, 117–119]. Functionally, the adult GM is enriched in genes associated with 
dietary utilization [115]. 
 
Noteworthy, although only a few phyla dominate the adult human gastrointestinal tract, at the 
species level, these are composed of ~1,800 genera and ~16,000 phylotypes. Furthermore, 
every person carries specific and dynamic subsets of ~160 species [109, 120]. This highlights 
the complexity of any study, in which the GM composition and/or changes in GM composition 
in health and/or disease are targeted. The microbial diversity, i.e. the number of different 
microbial species in a community, generally serves as an indicator of a "healthy gut", owing 
this role to its association with productivity, functioning, and stability [121, 122]. Both a 
reduced microbial diversity and perturbations of the microbial balance, so-called dysbiosis, in 
the gut have been associated with various adverse health outcomes, including obesity, type 2 
diabetes mellitus (T2D), inflammatory bowel disease, and other inflammatory and infectious 
diseases [108, 123, 124]. Also the changes in the microbial composition that take place during 
aging may affect host health, although it has remained controversial so far whether this 
remodelling is a cause (dysbiosis) or rather an adaptation to the aging processes [123]. 
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However, maintaining both a high microbial diversity and a balanced gut microbial composition 
appear to be crucial in healthy aging and longevity. 
 
1.4.3. Changes in the human gut microbiota composition in the elderly 
The gastrointestinal tract as well as dietary patterns undergo substantial changes with aging, 
shifting GM gradually over time [125–127]. In the elderly, the GM diversity is reduced 
compared with younger adults, while the inter-individual variation is increased [126]. Part of 
the GM instability in old age has been associated with stress, antibiotics, lifestyle and diet [128], 
while some alterations have been linked to age-related diseases such as obesity, T2D, and 
cardiovascular diseases (CVD) [129–133]. In addition, shifts in the dominant species occur; the 
amount of beneficial microorganisms declines and both facultative anaerobic bacteria and 
subdominant bacterial species increase, such as members of Bacteroidetes and Proteobacteria 
over Firmicutes (Clostridium cluster XIV, Fecalibacterium prausnitzii, and Bifidobacterium) 
[126, 134–136]. Susceptibility to pathogenic infections has been associated with depletion of 
Bifidobacterium in older adults [137]. The proliferation of pathobionts (resident microbes with 
pathogenic potential) together with the lower microbial diversity is hypothesized to contribute 
to the pro-inflammatory status in the elderly and to be a risk factor for chronic health conditions 
[125, 127, 138]. Moreover, a lack of microbiota-derived metabolites (i.e. short-chain fatty acids, 
SSFA) due to the reduction in beneficial bacteria (Clostridium cluster XIV, Fecalibacterium 
prausnitzii, and Bifidobacterium, etc.) has been associated with aging-related disorders such as 
irregular bowel transit, reduced appetite, frailty, weight loss, cognitive decline, hypertension, 
vitamin D deficiency, diabetes, arthritis, and sarcopenia [132, 139, 140]. Altogether, these 
findings substantiate the hypothesis that maintaining GM homeostasis is crucial for healthy 
aging and for achieving longevity [141–144]. Therefore, restoration of GM homeostasis in 
elderly at risk is likely to become a main challenge in the future, especially in view of the 
ongoing population aging. 
 
1.4.4. Signatures of longevity in the human gut microbiome 
The most profound changes in GM have been seen in centenarians. One of the unequivocal age-
related affliction is "inflammaging" (chronic low-grade inflammatory status [87]). In the gut, 
inflammation boosts aerobiosis and the production of reactive oxygen species, turning the gut 
into a disadvantageous environment for the strict anaerobic bacteria (e.g. Firmicutes) while 
uplifting the colonization of facultative aerobes (e.g. Enterobacteraceae, Enterococcaceae, 
Staphylococcaceae). These facultative microorganisms can compromise the immune 
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homeostasis in favor of a pro-inflammatory profile creating a vicious inflammatory cycle (as it 
has been demonstrated for mice [145]), which in turn may contribute to both frailty and the 
progression of diseases. Healthy LLI do not follow a linear pattern that continues to nourish the 
inflammatory cycle. Centenarians have been shown to exhibit a noticeable adaptive remodeling 
of the GM [135, 146, 147]. 
 
 
Figure 1.5. Proposed changes in the gut microbiota composition during aging and in extreme 
longevity ([146]). 
 
Among the multiple characteristics of the centenarians’ GM, one of the most prominent is the 
high microbial diversity (Figure 1.5) [136, 146, 147]. The increase in diversity entails a 
rearrangement of the core microbiota; for example, in centenarians from Italy, a reduction in 
the occurrence of the Clostridium cluster XIVa, an increment in Bacillus species and 
compositional changes in the Clostridium cluster IV [146] have been observed. The GM was 
also characterized by an increase in pathogenic species, such as Proteobacteria, 
Fusobacterium, Bacillus, Staphylococcus, Corynebacterium, and from members of the families 
Ruminococcaceae, Christensenellaceae and Micrococcaceae [135]. The proliferation of 
pathobionts like Proteobacteria, which may contribute to inflammaging, and a reduction in 
butyrate-producing bacteria, such as Fecalibacterium, Roseburia, Coprococcus, Blautia and 
Eubacterium have been reported in LLI from Italy, Japan and China [136, 146, 147]. This 
evidence has led to the hypothesis that the centenarians’ GM displays a particular signature 
embedded in a microbial community shaped by lifestyle, nutrition, geographical/population or 
social factors as well as genetics, which still remains to be determined [148]. 
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1.5. Aims of the thesis 
We need a better understanding of the mechanisms underlying aging; only this knowledge will 
enable us to eventually intervene in aging-related biological processes, influence or manipulate 
them for the better and thereby extent the healthy lifespan of humans. As aging is a highly 
complex phenotype, the present work aims at contributing to the growing body of evidence 
about aging mechanisms on three very different levels (Figure 1.6): 
 
1. Basic research in the immortal fresh water polyp Hydra vulgaris (Chapter I) 
2. Genetic analyses focusing on the heritable component of human longevity, a healthy aging 
phenotype (Chapter II) 
3. Investigations of the human intestinal microbiome and its role in healthy aging (Chapter III) 
 
On all these levels, the work requires the handling, management and analysis of diverse big 
data sets (microarray and next-generation sequencing transcriptomics (Chapter I), exome-wide 
SNP arrays (Chapter II), microbiome 16S rRNA sequencing data along with host genetic and 
phenotypic information (Chapter III)) and the application of cutting-edge statistical and 
computational methods. 
 
Figure 1.6. Overview of the three research projects. 
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CI, control individuals; COG, cluster of orthologous groups; KEGG, Kyoto Encyclopedia of 
Genes and Genomes; LLI, long-lived individuals; SNV, single nucleotide variant. 
 
1.5.1. Specific aims 
Chapter I 
The Hydra chapter comprises fundamental research on the genetically driven regulation of 
development and aging. Many genes and pathways are evolutionarily conserved and, 
consequently, a large number of orthologs of human genes have been found in the Hydra 
genome; FoxO is only one prominent example. Therefore, basic research in Hydra might 
contribute in the long-term to unravel evolutionary signatures of aging regulation, which may 
help to understand human aging. 
 
Specifically, molecular mechanisms underlying Hydra body compartmentalization, i.e. 
boundary formation and maintenance under constant proliferation, and the genetic contribution 
to these processes have remained largely unknown so far. Therefore, the aims of Chapter I are 
to: 
 
1. define the gene expression profile of the body parts of Hydra (foot, body, head and tentacles) 
using RNAseq techniques; 
2. subsequently determine by differential gene expression analyses the degree to which gene 
expression changes underlie the compartmentalization; 
3. identify which patterns in gene expression are altered when Hydra’s epigenome is disrupted 
employing a histone acetylation inhibitor. 
Eventually, the work aims to discover the regulatory mechanism(s) underlying the 
regionalization processes as well as to investigate a possible involvement of FoxO. 
 
Chapter II 
Despite extensive research efforts, there is still a huge knowledge gap about the genes that 
specifically contribute to human longevity – so far, only a handful of SNVs have shown 
consistent longevity-associations across population-cohorts. It appears plausible that apart from 
common susceptibility variants also (relatively) rare SNVs with large effect sizes that reside in 
coding regions may at least partly explain the missing longevity heritability. Previous studies 
focused almost exclusively on intronic or regulatory SNVs with limited success. In this 
subproject, exonic variants are investigated. This is the first study of this kind in Germans. An 
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exome-wide chip-based SNV case-control association analysis is conducted in a large cohort 
comprising more than 1,200 LLI including 599 centenarians. This project also involves the 
replication of results in Danish and French cohorts and an in-depth analysis of the genotyping 
data with bioinformatic methods. 
 
Chapter III 
The intestinal microbial composition changes during aging. However, these changes appear to 
depend on dietary patterns and/or geographic region. No systematic large-scale study over a 
broad age range, including LLI, has been conducted in Germans. Therefore, the aims of this 
subproject are to: 
 
1. identify age-related changes in the microbiome composition in healthy German individuals 
covering the age range between 19 and 104 years;  
2. determine to what extent host genetics (associated with gut microbial composition and 
metabolic syndromes) as well as environmental factors influence aging;  
3. investigate whether there are any specific microbial patterns in German LLI. 
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Abstract 
Despite being a defining feature of many animal taxa, much remains to be understood about 
boundary formation during development. Axial patterning of Hydra, member of the ancient 
phylum Cnidaria which diverged prior to the bilaterian radiation, involves a steady state of 
production and loss of tissue and is dependent on an organizer located in the upper part of the 
head. We show that the sharp boundary which separates tissue in the body column from head 
and foot tissue depends on histone acetylation. Histone deacetylation decomposes the boundary 
by affecting numerous developmental genes including Wnt components and prevents stem cells 
from entering the position dependent differentiation program. Overall, our results suggest that 
reversible histone acetylation is an ancient regulatory mechanism for partitioning the body axis 
into domains with a specific identity, which has been present in the common ancestor of 
cnidarians and bilaterians, at least 600 million years ago. 
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2.1. Introduction 
Boundary formation during animal development is important to establish tissue with regional 
identity along the body axis (Batlle and Wilkinson, 2012; Cayuso et al., 2015). Although 
destabilization of boundaries by cell intercalation or physical disruption and dispersal during 
morphogenesis directly interferes with normal development (Dahmann et al., 2011a), the 
molecular principles by which boundaries are maintained throughout the life of an organism 
have remained undiscovered. 
 
In Hydra (Figure 2.1 A), cell proliferation takes place continuously along the single apical-
basal body axis but is restricted to the gastric region of the animal (Figure 2.1 B) (Campbell 
and David, 1974; David and Campbell, 1972). The division of stem cells in this region causes 
a constant displacement of differentiated cells towards extremities (head and foot) and buds 
(Campbell, 1967). Due to these tissue dynamics, patterning signals are constantly active in the 
adults, which not only allows polyps to proliferate by budding continuously but also is 
constantly challenging the formation of stable boundaries. Such boundaries are those who 
strictly separate the stem cell populations in the body column from the committed or terminally 
differentiated cells in the head and foot compartments (Figure 2.1 B-C). 
 
The morphologically invisible boundary which separates body column and head tissue 
correlates with distinct expression domains of both transcription factors and signalling as well 
as effector molecules (Figure 2.1, D-H) (Boehm et al., 2012; Endl et al., 1999b; Weinziger et 
al., 1994; for review see Böttger and Hassel, 2012). Transcriptional regulators potentially 
involved in establishing regional identity along the body axis include CnOtx, HyAlx, Budhead 
and Prdl-a (Gauchat et al., 1998; Martinez et al., 1997; Smith et al., 1999, 2000). Genes 
demarcating the basal end of the tentacles and thus the boundary between head and body 
column tissue include HyDsh, HvWnt8 and Hmfz2 (Minobe et al., 2000; Philipp et al., 2009). 
Hydra specific effector gene ks1 (Endl et al., 1999b) is strongly expressed in ectodermal 
epithelial cells immediately after they leave the body column compartment and before they 
terminally differentiate to become head specific “battery” epithelial cells (Figure 2.1 A and 
D). 
 
The molecular mechanisms maintaining stable boundaries in the constantly proliferating Hydra 
tissue remain largely unknown. It is also not known to what extent changes in gene expression 
underlie the regionalization, nor do we understand how these changes are regulated. The 
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mechanistic nature of the control system that specifically sets the head-body column boundary 
along the body axis is therefore still unknown. Towards this goal, we here combined genetic, 
cell biological, molecular and computational approaches. We find that the molecular circuitry 
at the sharp boundary which separates tissue in the body column from head tissue deploys 
numerous developmental genes and depends on histone acetylation. Histone deacetylation 
decomposes the boundary and transforms head tissue into body column-like tissue with 
constant mitotic activity. Overall, our results suggest a model in which partitioning of the Hydra 
body axis into domains with specific identity involves epigenetic programming mediated by 
histone acetylation. 
 
2.2. Results 
 
2.2.1. Comparative transcriptomics identifies compartment specific genes  
To uncover the encoded genetic logic underlying the maintenance of region-specific 
compartments in adult Hydra, we profiled the transcriptome from six defined regions along the 
body column (Figure 2.1 C). The assembly of 256702 contigs led to the identification of 29358 
transcripts. As a quality threshold and to minimize variability, we concentrated on 14127 genes 
corresponding to transcripts which appeared in at least three libraries with at least two counts 
per million reads. Three independent biological replicates for each region showed high 
reproducibility (Figure 2.2 A). Principle component analysis (PCA) revealed that component 
1 and 2 (PC1, PC2) were sufficient for separating the samples into four defined groups:  
tentacle, head, foot, and all the samples from the three body parts (B1, B2 and Bb) (Figure 2.2 
A). The first component (PC1) distinguished body column expressed genes from head and 
tentacle specific transcripts and accounted for 19 % of the variability. The largest differences 
in this dataset were between the tentacles and the body region (Figure 2.2 A). These two regions 
exhibited 2199 differentially regulated genes. The 9 percent of them were upregulated, and 6.5 
percent downregulated (Supplementary figure 2.1). When comparing head and body column 
tissue, from 1022 differentially expressed genes 4.5% were up and 2.6% downregulated. 
Moreover, from 967 genes differentially expressed in tentacle and foot tissue, 4% were up and 
3% downregulated suggesting a quite distinct transcriptome profile for these two 
compartments. The tentacle and head programs were relatively similar to each other with less 
than 1% up or downregulated genes from a total of 137 genes. 
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2.2.2. Functional annotations outline the compartment specific gene expression program 
One goal of the study was to delineate a region-specific gene expression profile along Hydra´s 
body column to understand the mechanistic underpinnings. As a first step, we used the 
differentially expressed genes that were expressed at least 2-fold higher in region-specific 
samples and plotted them in the PCA correlation circle following their annotation in KEGG 
pathways (http://www.genome.ad.jp/kegg/) (Figure 2.2 B). Genes contributing to body column 
tissue (right side of the circle) are mostly associated with terms such as protein processing, 
pyrimidine metabolism, ribosome and spliceosome pathways. Terms enriched in the tentacle 
and head samples (left side of the circle) are associated with cell adhesion, ECM-receptor 
interaction, calcium signalling, focal adhesion and the MAPK pathway (Figure 2.2 B). Terms 
enriched in foot samples (upper side of the circle) are associated with cell adhesion, MAPK 
(FGFR) and Wnt signalling pathway (Figure 2.2 B). Terms enriched in head tissue (lower part 
of the circle pathway) are associated with other components of the Wnt signalling pathway as 
well as oxidative phosphorylation and phagosome formation (Figure 2.2 B). 
 
To gain further insight into the extent of gene expression change between the different regions 
along the body column, we computed the transcriptome divergence between adjacent tissue 
regions (Figure 2.2 C). We included all differentially expressed genes (adjusted P-value < 0.05) 
with at least two-fold change between the two compartments to uncover the set of genes 
responsible for their identity. This process resulted in 1310 genes that were further classified 
based on the Gene Ontology Biology Process terms (http://www.geneontology.org/) and plotted 
according to their expression (counts per million) in each region of the body column (Figure 
2.2 C). Interestingly, for each body region, we also identified a high number of genes with an 
unknown Gene Ontology annotation, which we considered as “orphans” (Figure 2.2 C). 
Orphan genes have been suggested to be involved in species-specific processes and to have 
effector functions (Khalturin et al., 2009; Neme and Tautz, 2013; Tautz and Domazet-Lošo, 
2011). 
 
To identify genes that behave similarly and might operate in networks, we next cluster all 
differentially expressed genes (2497 with adjusted P-value < 0.05) (Figure 2.2 D). The clusters 
were sorted by their expression trend along the body axis and grouped according to particular 
expression patterns (upregulated in one or more compartments). Four BCs where considered 
for further analysis (Figure 2.2 D): genes upregulated in tentacle and head tissue (dark blue in 
Figure 2.2 D); genes upregulated in foot tissue (yellow in Figure 2.2 D); genes upregulated in 
36 
 
both extremities, i.e. tentacle head and foot (light blue in Figure 2.2 D); and genes specifically 
upregulated in the body column (red in Figure 2.2 D). 
 
2.2.3. Metabolism, cell proliferation and adhesion pathways contribute to the boundary 
between head and body 
In a next step, we characterized the differentially expressed genes of each of the four “BCs” by 
identifying KEGG pathway terms enriched in these gene sets (Figure 2.3). We considered only 
pathways where more than 10 % of the corresponding members could be identified in our data 
set. 
 
When analyzing differentially expressed genes enriched in body column tissue, we observed 
three distinct KEGG categories (Figure 2.3). The first one includes terms associated with DNA 
replication, cell cycle regulation, mismatch repair and nucleotide excision pathway (Figure 2.3, 
Supplementary figure 2.2). This is consistent with the well-known proliferation processes that 
occur in this region (Campbell, 1967; Bosch et al., 2010). The second category of terms 
enriched in the body column samples are genes involved in metabolism. We found in particular, 
terms associated with glutathione metabolism, synthesis of purine and pyrimidine, cysteine and 
methionine production, oxidative phosphorylation (OxPhos) and One-carbon (1C) pool by 
folate to be enriched in the Hydra body column. The third category of terms enriched in the 
body column samples concerns processing and degrading of proteins. Components of both the 
ubiquitin proteolysis and proteasome pathway are differentially expressed with some of them 
upregulated in the terminally differentiated tissue. 
 
KEGG pathways defining terminally differentiated Hydra tissue involve the Ca++/ 
Phosphatidylinositol system as well as cell-adhesion/cytoskeleton-associated processes 
(Figure 2.3). With regard to the Ca++/ Phosphatidylinositol system, essential components of 
the phosphatidylinositol signal transduction cascade including Phospholipase C (PLC), protein 
kinase C (PKC) and calmodulin are transcriptionally upregulated in differentiated Hydra tissue 
(Figure 2.3 and Supplementary figure 2.2). Terminally differentiated tissue was also found 
to be characterized by the expression of key components of the inositolphosphate-metabolism 
pathway such as IP3K kinase, PI4K kinase, PI(3)P5K kinase and IP5 phosphatase 
(Supplementary table 2.2). 
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2.2.4. Inhibition of histone deacetylases (HDAC) breaks down head/body column 
boundary 
We generated transgenic animals in which the body-head boundary can be visualized through 
the expression of reporter genes, as a system for positional dependent gene expresion. Embryo-
microinjection of a construct Ks1::GFP /Actin::dsRED (see supplement) yielded polyps which 
expressed eGFP in ectodermal cells in the head and dsRED in the whole body as a marker of a 
positive transgenic cell (Figure 2.1 A; Figure 2.4 A). Exposure of these polyps to low doses 
(2- 10nM) of a potent and specific inhibitor of histone deacetylase (Trichostatin A, TSA) 
resulted in animals which progressively lost terminally differentiated tentacle and head tissue 
(Figure 2.4 A-C). Tissue in the body column apparently was not affected. This led us to address 
the role of histone acetylation in the establishment and maintenance of the head/body column 
boundary. 
 
Further, we detected the complete repertoire of histone deacetylases (HDAC) including 
transcripts and gene models corresponding to each of the HDAC groups described in Homo 
sapiens (HDAC1/2, 3, 4/5/7/9, 6, 8, 11) in the genome of Hydra magnipapillata (Chapman et 
al., 2010) and in the transcriptome of Hydra vulgaris AEP (Hemmrich et al., 2012) 
(Supplementary figure 2.3 A). Moreover, when transplanting TSA-treated Hydra tissue to 
untreated tissue followed by immunohistochemical analysis, we discovered an accumulation of 
acetylated histone 3 (H3ac) in the nuclei in TSA treated tissue (Supplementary figure 2.3 B 
Anti-H3ac +TSA) in comparison to untreated control tissue (Supplement 4, B, Anti-H3ac 
DMSO) indicating that TSA suppresses the activity of Hydra´s HDAC leading to an increase 
in histone acetylation. 
 
To link the morphological changes caused by TSA treatment (Figure 2.4 A-C) to the gene 
expression profiles, we used a microarray analysis. A PCA was employed to inspect the 
expression profiles of the head and upper body tissue (Head and Body 1, see Figure 2.1 B) 
when the polyps were exposed to 2.5 or 10nM of TSA (Figure 2.4 D). TSA responsive 
expression patterns were highly consistent in three independent replicates and clustered 
together according to the origin of the tissue and the TSA concentration. Interestingly, the PC1, 
which explains 44.2% of the variability in the dataset, clearly depict the transition of the 
expression profile between head and body under TSA treatment (Figure 2.4 D). TSA 
responsive functional classes contributing to this shift include genes involved in calcium 
signalling, pyrimidine metabolism, focal adhesion, MAPK signalling (FGF), regulation of actin 
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cytoskeleton, and the ligands of Wnt signalling pathway (Figure 2.4 E). In addition, genes 
involved in cell cycle, purine metabolism, pyrimidine metabolism, RNA degradation, RNA 
polymerase, spliceosome and ubiquitin-mediated proteolysis characterized the TSA treated 
head samples (Figure 2.4 E). Apparently, these functional processes are a distinguishing factor 
between head to body column tissue. The PC2 explains 24.3% of the variability and noticeably 
discriminates among TSA concentrations. Among the TSA sensitive genes, we highlight those 
involved in arginine and proline metabolism, mitochondrial genes, oxidative phosphorylation, 
purine metabolism and tryptophan metabolism as well as apoptosis, cell cycle, MAPK 
signalling (FGF/FGFR), and peroxisome and pyrimidine metabolism (Figure 2.4 E). 
 
To investigate the extent to which TSA treatment changes the expression profile along the body 
axis, we next identified the differentially expressed transcripts and classified them into clusters 
(Figure 2.4 F and G and Supplementary figure 2.4). Interestingly, plotting the genes 
differentially expressed in TSA treated head tissue positioned their expression within the body 
column clusters or nearest to body column gene expression fashion (Figure 2.4 F and G and 
Supplementary figure 2.4 A and B). This analysis revealed, that inhibition of Hydra´s HDAC 
strongly affected the expression profile of cells in terminally differentiated head tissue and 
causes them to adapt a more body-like expression mode. 
 
Having demonstrated that HDAC is involved in shaping the gene expression profile along the 
Hydra body axis, we next asked which pathways are involved. Thus, based on KEGG 
annotation of the differentially expressed genes, we found that TSA treatment in head tissue 
induces the expression of genes involved in cell cycle, DNA replication, spliceosome, TCA 
cycle, ubiquitin-mediated proteolysis and oxidative phosphorylation (e.g. cluster 1, see Figure 
2.4 F). This analysis also showed that TSA treatment causes cells in the head region to under-
express genes (e.g. cluster 6, 7 and 10, see Figure 2.4 G and Supplementary figure 2.4 A and 
B) involved in MAPK, insulin, hedgehog and calcium signaling as well as the WNT signaling 
pathway. The fact that several components of the Wnt signalling pathway are prominently 
expressed in the head (Hobmayer et al., 2000; Nakamura et al., 2011; Petersen et al., 2015), and 
that body column tissue is characterized by the expression of cell cycle genes (Buzgariu et al., 
2018) raised the hypothesis that histone deacetylation establishes and maintains the boundary 
between head and body column tissue. We therefore, targeted genes involved in cell cycle and 
stem cell proliferation as well as genes from the Wnt signaling pathway and examined the 
effects of TSA treatment on their expression. 
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2.2.5. Cell cycle control and histone deacetylation 
KEGG analysis revealed numerous genes involved in cell cycle control to be differentially 
expressed upon TSA treatment (Figure 2.5 A).  The majority of the transcripts belonging to 
this pathway are predominantly expressed in the body region which corresponds with the 
localization of the three stem cell linages in Hydra (Red boxes in Figure 2.5 A). Examples 
include cyclins A, B, E and H, CDK1 and CDK4, 6, E2F4, 5, HDACs, and the APC/C complex. 
While only few cell cycle genes are up-regulated in untreated head tissue (blue boxes in Figure 
2.5 A), a number of them is sensitive to TSA treatment (orange boxes in Figure 2.5 A). 
Intriguingly, genes encoding Cyclin A, B and E and CDK1 as well as components of the APC 
complex and ubiquitin ligase Cdh1 were part of this altered gene expression profile. 
 
Direct visualization of cells in S-phase along the body column by using 5-bromo-2'-
deoxyuridine (BrdU) labelling demonstrated an increased number of S-phase cells in the body 
column of treated polyps (Figure 2.5 B-D). Intriguingly, inhibition of HDAC appeared to allow 
cells localized in terminally differentiated head tissue to replicate their DNA (Figure 2.5 B-D). 
We also noted that with increasing concentrations of TSA the tentacle length became much 
shorter and that S-phase cells can be monitored even in the most terminal tissue (Figure 2.5 D). 
Overall, our analysis strongly indicated that inhibition of HDAC affects cell cycle genes along 
the body column and effectively expands the zone of proliferation to include terminally 
differentiated tissue. 
 
To address possible consequences of this expanded zone of proliferation, we monitored the 
expression of transcription factor FoxO along the body column using a transgenic line which 
expresses GFP under the control of the FoxO promoter (Figure 2.5 E). We previously have 
shown that Hydra FoxO is a key regulator of stem cell proliferation (Boehm et al., 2012). 
Consistent with our observation of the impact of TSA cell proliferation (Figure 2.5 A-D), FoxO 
transgenic polyps show FoxO expression along the whole animal even ectopically in the most 
terminal tissue regions (Figure 2.5 F-H). Interestingly, treatment with increasing 
concentrations of TSA not only expanded the zone of activity of FoxO; the TSA-induced high 
and ectopic level of FoxO activity also resulted in polyps with multiple body axes (Figure 2.5 
F-H) indicating interference of FoxO with the endogenous patterning system. 
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2.2.6. Wnt signaling and histone deacetylation 
Patterning in Hydra is under control of the Wnt pathway (Gee et al., 2010; Gufler et al., 2018; 
Hobmayer et al., 2000; Iachetta et al., 2018; Lengfeld et al., 2009; Nakamura et al., 2011; 
Petersen et al., 2015). To investigate the impact of histone deacetylation on the Wnt signalling 
pathway, we used KEGG analysis to ask which of the TSA-dependent gene clusters (Figure 
2.4) can be classified as genes involved in the Wnt pathway. Figure 2.6 A reveals that many 
components of the Wnt pathway in Hydra are differentially expressed between head and body 
column tissue. Seven Wnt encoding genes, two Frizzled transmembrane receptors, Dishevelled, 
Axin, β-Catenin and GSK-3 are restricted to or upregulated in the head region (see Figure 2.6 
A, blue boxes). Other transcripts including two other transmembrane Frizzled proteins, a casein 
kinase II (CK2), a protein phosphatase (PP2A) and the transcription factors cMyc and cJun are 
more abundant in the body region (Figure 2.6, A Red boxes). Intriguingly, and consistent with 
our previous findings of TSA-treated head tissue to become more body column like (Figure 
2.4 F and G), our data reveal that the head-specific expression of two Wnt encoding genes 
(Wnt1 and Wnt5) are downregulated upon HDAC inhibition (Figure 2.6 A, light blue boxes). 
Figure 2.6 B summarizes our current understanding of how histone hyperacetylation affects 
Hydra by extending the stem cell containing body region and reducing the differentiated 
compartments.  
 
2.3. Discussion  
2.3.1. Principles of boundary formation in the early emerging metazoan Hydra 
Decades of studies have established the basic features of patterning in Hydra (Bode, 2011; 
Gierer, 2012; Koinuma et al., 2000; Meinhardt, 2012; Watanabe et al., 2014). The single body 
axis is established during embryogenesis and maintained in adult polyps by local Wnt activity 
(Gee et al., 2010; Gufler et al., 2018; Hobmayer et al., 2000; Nakamura et al., 2011). 
Transcription factors including c-myc (Ambrosone et al., 2012; Hartl et al., 2014) and FoxO 
(Boehm et al., 2012; Mortzfeld and Bosch, 2017) contribute to maintaining continuous stem 
cell proliferation and differentiation in the body column. Here we present a multidimensional 
gene expression dataset from carefully selected regions along the Hydra body axis which 
provides a foundational gene expression resource encompassing central aspects of patterning 
in Hydra. It supports earlier findings of a spatial (i.e. region-specific) organization of gene 
expression in adult polyps (Figure 2.1) and reveals that numerous not conserved “orphan” 
genes along with conserved regulators and pathways contribute to the patterning process 
(Figure 2.2). The sensitivity of the expression of many of these genes to experimentally induced 
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changes in histone acetylation (Figure 2.4) reveals that boundaries between compartments are 
formed and maintained by mechanisms that depend on reversible histone acetylation and 
deacetylation. 
 
Our results suggest that specific genes are in charge of the boundary maintenance along the 
body axis. Among these genes, we found members of the cell cycle pathways such as cyclins, 
cyclins-dependent-kinases (CDKs), proteins forming complexes responsible for DNA 
replication and the transcription factors c-myc and FoxO (Figure 2.3, Figure 2.5 A, and 
Supplement ary figure 2.2). The body column was also characterized by the upregulation of 
metabolic pathways mainly related to energy supply and protein processing. In addition, many 
enzymes are upregulated in the body column for the production of purines and pyrimidines, 
OxPhos, glutathione, cysteine and methionine metabolism (Figure 2.2 B, Figure 2.3, Figure 
2.4 E).  
 
Interestingly, many of these pathways are known to be important in maintaining the stemness 
of pluripotent stem cells in different organisms (Shiraki et al., 2014; Shyh-Chang et al., 2013). 
The OxPhos pathway, for example, is used by mitochondria in totipotent mammalian stem cells 
and differentiating embryonic stem cells (ESCs) for oxidation of pyruvate (Shyh-Chang et al., 
2013). Moreover, cell growth of undifferentiated human ESCs and induced pluripotent stem 
cells (iPSCs) is dependent on large amounts of methionine; and deprivation of this amino acid 
result in cell growth inhibition and cell cycle arrest (Shiraki et al., 2014). A particularly 
interesting class of metabolic terms enriched in the body column was associated with S-
Adenosyl L-methionine (SAM) production (Supplementary figure 2.2). Since SAM is 
considered a universal methyl donor (Ducker and Rabinowitz, 2017), it may play a major role 
in epigenetics because it is the principal methyl substrate used by methyltransferases to 
methylate metabolites, RNA, DNA, and proteins including histones (Mentch and Locasale, 
2016).  After the methyl group from SAM is transferred to an acceptor substrate, S-
adenosylhomocysteine (SAH) is produced. In turn, SAH is hydrolyzed to adenine and 
homocysteine, and to complete the cycle, the homocysteine can be re-methylated via 
methionine synthase to produce again methionine. 
 
At the same time, genes encoding phosphatidylinositol- and related phosphoinositides-
modifying enzymes are expressed in terminally differentiated head tissue (Figure 2.3). One 
regulatory step later, enzymes up or downstream the conventional phosphatidylinositol 
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signaling pathway including PKC and PLC, diacylglycerol kinase and calmodulins are also 
differentially upregulated in head tissue (Figure 2.3). These findings support earlier studies in 
Hydra (Hassel and Bieller, 1996; Müller, 1990, 1995). They reported severe defects in 
patterning processes when, e.g., PKC is chemically inhibited. Interestingly, these pathways 
were previously associated with trophoblast differentiation (Kent et al., 2010), keratinocyte 
differentiation (Haase et al., 1997), and in the regulation of growth and differentiation of 
hematopoietic cells (Michell et al., 1990) and neurons (Loss et al., 2013).  
 
Besides, many genes involved in the architecture of the actin cytoskeleton including F actin, 
myosin, integrins, Tallins (Figure 2.3, Supplementary figure 2.2); calcium signalling 
pathways, focal and cell adhesion are upregulated in differentiated head tissue in comparison 
with the body column. Head tissue is also characterized by the expression of genes encoding 
extracellular components including collagens, thrombospondin, and ligands such as fibroblast 
growth factors. Another group of genes differentially expressed in head tissue encodes the 
anaphase-promoting complex/cyclosome (APC/C) which is a multifunctional ubiquitin-protein 
ligase that targets various substrates for proteolysis inside and outside of the cell cycle (Alfieri 
et al., 2017). 
 
The complex expression patterns are controlled and maintained by histone deacetylases. 
Prolonged inhibition of histone deacetylase by TSA results in progressive loss of terminally 
differentiated head tissue (Figure 2.4 C). Ectopic upregulation of cell cycle genes (Figure 2.4 
F, Figure 2.5 A) and the sudden appearance of actively replicating cells in the most apical 
region of the body axis (Figure 2.5 B-D) indicates that repression of histone deacetylases 
prevents the correct onset of the differentiation program at the head/body column boundary. 
HDAC repression also affects both the cell-cycle regulatory complex APC/C and genes APC 
1,8,10 which normally are only expressed in the body column as well as genes encoding 
components of the SCF complex, which mediates ubiquitination of proteins and has been 
associated with the degradation of cell cycle proteins. These repressions also remove the 
confinement of FoxO expression to the body column region (Figure 2.5 F-H). 
 
Previous studies have provided evidence that at least some of the HDACs including HDAC 1,2 
and 3 are regulated by phosphatidylinositides (Millard et al., 2013a, 2017). Our dataset shows 
that many genes involved in the phosphatidylinositol pathway and inositol phosphate 
metabolism are upregulated in tissue from the apical (head) or basal (foot) region (Figure 2.3 
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and Figure 2.7 C). The strikingly strong presence of phosphatidylinositides in differentiated 
(head and foot) tissue, therefore, could cause the region-specific full activation of HDAC (see 
also Watson et al., 2016). 
 
To summarize, whereas in Hydra a common organizer is used to initiate and to maintain the 
region-specific expression of both conserved as well as un-annotated genes, the different and 
complex patterns of gene expression at the head/body boundary are controlled by histone 
deacetylases (HDACs) and thus by epigenetic regulators which regulate transcription through 
chromatin modification without directly binding response elements on DNA. We conclude 
(Figure 2.7 A-D) that reversible histone acetylation and deacetylation appears as key 
component maintaining the sharp boundary between the stem cell (body column) and terminally 
differentiated (head) compartment in Hydra.  
 
2.3.2. An evolutionary perspective on HDAC and boundary formation: parallels between 
Hydra and patterning in other animals and plants 
Besides Hydra, there are other invertebrates and also vertebrates in which an interference 
(mutation, repression) with HDACs activity affects patterning and embryonic development (de 
Ruijter et al., 2003). For example, exposure of Drosophila to Trichostatin A causes 
developmental defects (Ikegami et al., 1993; Nemer, 1998). Mutations in the Drosophila hdac-
1 homolog Rpd3 (Figure 2.7 E) are lethal and lead to a paired-rule segmentation phenotype 
with disturbed parasegmental boundary formation (Mannervik and Levine, 1999; Mottus et al., 
2000; reviewed by Dahmann et al., 2011b; Umetsu and Dahmann, 2010). Moreover, treatment 
of sea urchin embryos with 10ng/ml TSA induces hyperacetylation of histones in cells of 
blastula stages. Development of the treated embryos is arrested at an early gastrula stage, 
indicating that a developmental window in the midblastula stage is sensitive to the normal cycle 
of histone acetylation and deacetylation (Ikegami et al., 1993). Interfering with HDAC activity 
also affects vertebrate development. Homozygous hdac-1 zebrafish knock-out mutants show 
numerous developmental abnormalities in the heart and neural epithelial tissue (Pillai et al., 
2004). Similarly, treatment of Xenopus frog embryos with TSA leads to developmental defects 
in the head and tail region accompanied by embryonic lethality (Almouzni et al., 1994). In mice, 
hdac-1 knockout led to severe proliferation defects, growth retardation and abnormal head and 
allantois development followed by embryonic lethality before E10.5 (Lagger et al., 2002). 
 
Interestingly, as in continuously proliferating Hydra, the remarkable ability of some plants to 
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retain populations of dividing undifferentiated cells (meristems) also depends on histone 
acetylation. It is widely known that angiosperms, root and shoot growth is maintained and 
regulated through the activity of the apical meristems (Shishkova et al., 2008). ‘Potentially, the 
plant axis can grow indefinitely in length through the activity of its apical meristem and in 
width through the activity of the vascular cambium (cited from Sinnott, 1960). In the 
Arabidopsis root (Figure 2.7 F), stem cells localized in the apex of the root meristem are 
characterized by relatively weak and dynamic histone-DNA interactions. However, the constant 
supply of new cells from the root meristem towards the differentiation zone results in a 
progressively stronger bond of chromatin to histones (Rosa et al., 2014). In fact, histone 
hyperacetylation by means of TSA leads to an increase in meristem size (schematically depicted 
in Figure 2.7 F) and in the expression of the meristem marker RHD6 in cells from the 
differentiation zone, together with an overall decrease of histone stability (Rosa et al., 2014). 
These results reveal a role for acetylation and histone stability in determining meristem 
competency and root development (Rosa et al., 2014). 
 
The observations as portrayed in Figure 2.7 D to F for Hydra, Drosophila and Arabidopsis 
indicate an evolutionary conserved and therefore the important role of histone acetylation in 
regulating both differentiation and cell cycle progression in a spatially controlled framework 
and for partitioning the body axis into domains with a specific identity. Continuously 
proliferating Hydra polyps, therefore, may present a unique opportunity to decipher the 
molecular mechanisms regulating boundary formation beyond the spatial and temporal 
restrictions imposed by most animal embryos. 
 
2.4. Materials and methods 
Animals and culture conditions 
Experiments were carried out using Hydra magnipapillata and Hydra vulgaris strain AEP. All 
animals were cultured identically under constant environmental conditions that include: culture 
medium, Artemia salina as food, and temperature according to standard procedures at 18°C 
(Lenhoff and Dubois Brown, 1970). 
 
Generation of transgenic H. vulgaris strain AEP 
For reporter of Ks1 (GenBank, AM161049.1) and FoxO (GenBank JX118843), transgenic 
polyps were generated, expressing GFP under the control of Ks1 and FoxO promoter 
respectively. Therefore, the promoter region of Ks1 and FoxO (aprox. 1.1 kb. for Ks1 and 1.5kb 
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for FoxO from the 5’ flanking region) were cloned into ligAF vector (Wittlieb et al., 2006) in 
front of enhanced green fluorescent protein (eGFP) and followed by actin terminator. A second 
cassette was included with actin-promoter driving the expression of red fluorescent protein 
(dsRED) and finalized through actin terminator (figure 5, E). The resulting vector was injected 
into H. vulgaris (AEP) embryos as previously described (Wittlieb et al., 2006). Founder polyps 
showed stable dsRED expression in a group of ectodermal cells and were expanded further by 
clonal propagation.  
 
In situ hybridization 
Gene expression analysis was performed by whole-mount in situ hybridization as described 
previously (Khalturin et al., 2007). The gene expression pattern was detected with digoxigenin 
(DIG)-labelled RNA probes. Anti-sense RNA probes were designed to recognize specifically 
the sequence of the following genes: Ks1 (GenBank, AM161049.1), foxO (GenBank 
JX118843), and at metazome server: HMG3b3 (Hma2.227348) Aristales Alx (Hma2.219326), 
KLF13 (Hma2.209274). DIG-labelled sense probes ware used as a control. Signal was obtained 
using anti-DIG antibodies conjugated to alkaline phosphatase /1:2000, Roche Diagnostics) and 
NBT/BCIP staining solution (Roche).  
 
Immunohystochemistry 
Immunohistochemical detection of acetylated histone 3 in whole mount Hydra preparations 
was performed following standard procedures (Engel et al., 2002) using polyclonal rabbit anti-
Histone H3 (acetyl K9 + K14 + k18 + K23 + K27) antibody – ChIP Grade (1:2000) and Alexa 
488 anti-rabbit antibody (1:1000). Phalloidin and TO-PRO staining was done as described 
previously (Anton-Erxleben et al., 2009). Confocal laser-scanning microscopy was done using 
TCS SP1 laser-scanning confocal microscope (Leica). 
 
BrdU labelling and detection 
For analysis of cell with active replication in the whole polyp, animals were exposed for 3h to 
5mmol l-1 of 5-bromo-2’-deoxyuridine (BrdU) (Holstein et al., 1991). Detection of 
incorporated BrdU was carried out according to Holstein et al. (1991) using monoclonal anti-
BrdU antibodies (1:100, Roche), alkaline phosphatase-conjugated sheep-anti-mouse secondary 
antibodies (1:5000, Millepore ®) and NIBT/BCIP staining solution (Roche).  
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Microscopy analysis 
Fluorescent images of transgenic polyps were taken on a Zeiss Axioscope fluorescence 
microscope equipped with an Axiocam (Zeiss) digital camera. Laser-scanning confocal data of 
transgenic cells were acquired by using LeicaTCSSP1 CLS microscope. The in situ 
hybridization preparations were analysed using Zeiss Axioscope microscope.  
 
Phylogenetic analysis 
For the calculation of the HDAC tree, an amino acid alignment of 7 HDAC sequences from 
Hydra magnipapillata, 5 HDAC sequences from Hydra vulgaris AEP transcriptome, 11 
HDACs from humans and one homologue from Saccharomyces cerevisiae HDA1 were used. 
The sequences were aligned using Clustal W with the standard parameters for multiple 
alignments (Thompson et al., 1994). All ambiguous positions were removed for each sequence 
pair, giving a total of positions in the final data set of 1462. The statistical method used to make 
the reconstruction was Neighbour-joining and the bootstrap values were calculated based on 
1000 replicates, this was implemented by using MEGA 6 (Tamura et al., 2013) (with p-distance 
model). 
 
Chemical interference  
For the chemical interference experiments the polyps were incubated in 5 or 10nM of TSA or 
DMSO (control polyps) for 24, 48 or 72 hours. Hydra medium was supplemented with a stock 
solution of TSA (1000nM in DMSO) to a final concentration of 5 or 10nM. TSA was obtained 
from Sigma-Aldrich (catalog number T8552). The control polyps were kept in Hydra medium 
with the corresponding amount of DMSO for each concentration.  
 
Hydra axial transcriptome, assembly and annotation 
Total RNA was isolated using TRIzolTM reagent (InvitrogenTM) according to manufacturer’s 
protocol and followed by a purification protocol using PureLinkTM RNA mini Kit columns 
from Ambion®. For the RNAseq experiments total RNA was isolated from 6 Hydra -body 
sections (Tentacles, Head, Body 1, Body 2, Body bud and Foot, Figure 1,C ) using TRIzolTM 
reagent (InvitrogenTM) according to manufacturer’s protocol and combine with a purification 
protocol using PureLinkTM RNA mini Kit columns from Ambion®. For them we pooled from 
150-200 sections of each polyp part.  RNA quality was measured with the Agilent RNA Nano 
Kit, for the individual pools. Samples with RIN values above 7.5 were used for sequencing. 
Library preparation was done using the Illumina TruSeq stranded Total RNA preparation, 
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following manufacturers’ instructions. Sequencing was done in Illumina MiSeq sequencer. 
Transcripts were assembled using Trinity v2.1.1 (Haas et al., 2013). Trinity was run with –
min_kmer_cov 2 and –min_contig_length 200 to reduce memory requirements and discard 
contigs shorter than 200 bp. In all other respects, default parameters were used. In total, 
58.258.591 raw paired reads were processed. Poor quality reads shorter than 25bp were 
removed. The first ten nucleotides of each read and adapter contamination were also removed 
prior further analysis. Poor quality nucleotides (average base quality over a four bp sliding 
window < 5) were trimmed. The remaining 52.631.072 paired reads were used for de novo 
transcriptome assembly. The assembled transcriptome was assessed for gene completeness 
using the BUSCO (Benchmarking Universal Single-Copy Orthologs) library (Simão et al., 
2015). 
 
After Trinity assembly, annotation was performed using Trinnotate pipeline v3.0.1 
(https://trinotate.github.io/). Gene open reading frames (ORFs) were predicted using 
TransDecoder v5.0.0 (http://transdecoder.github.io). Only the longest predicted ORFs that were 
at least 100 amino acids long were retained. Obtained ORFs were blasted against the SwissProt-
UniProt database (v06.2017) with an E-value cut-off of 10−5 using BlastP (Altschul et al., 
1990). Additionally, the software Hmmer v.3.1b2 was used for protein domain identification 
(Finn et al., 2015), Tmhmm v.2.0c for prediction of transmembrane helices in proteins (Krogh 
et al., 2001) and SignalP v.4.1 to predict signal peptide cleavage sites (Petersen et al., 2011). 
 
Differentially expressed genes along Hydra body parts 
Differentially expressed (DE) genes among the three parts of Hydra’s body plan (foot, body, 
and head) were identified using the R-package DESeq2 (Love et al., 2014). RNAseq libraries 
from each body part were mapped to the de novo Hydra transcriptome and the transcripts were 
quantified using RSEM (Li and Dewey, 2011). Transcripts with more than two counts per 
million in at least three libraries were kept for further analysis. Correction for batch effects in 
the samples was applied through a surrogate variable analysis using the sva R-package (Leek 
JT, Johnson WE, Parker HS, Fertig EJ, Jaffe AE, Storey JD, 2017). Negative binomial 
generalized linear models in DESeq2 were used to determine the differential expression of the 
transcripts among the body parts. Transcripts with a significance cut-off of adjusted P-value < 
0.05 were selected for comparisons. The P-value was adjusted according to the false discovery 
rate (FDR) (Benjamini and Hochberg, 1995). 
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Cluster and GO enrichment analysis 
The expression patterns of the DE transcripts were analysed with a hierarchically clustering 
tree. A regularized log transformation (Love et al., 2014) of the expression of DE transcripts 
and the Euclidean distance was used to construct the tree. The clusters of similar expression 
patterns were calculated cutting the tree at 50% of the maximum height. 
 
Microarray hybridization and analysis 
Custom Agilent Gene Expression Microarray was designed using the H.magniapillata gene 
models available at Metazome (https://metazome.jgi.doe.gov/pz/portal.html). For the 
microarray analysis of gene expression, total RNA was isolated from head and the first part of 
the body (Body 1, Figure 1, C) of polyps treated with 2,5 TSA or 10nM TSA or the control 
polyps in DMSO using TRIzolTM reagent (InvitrogenTM) according to manufacturer’s 
protocol and combine with a purification protocol using PureLinkTM RNA mini Kit columns 
from Ambion®. About 400ng of total RNA were labelled with Cy3 using the one-colour Quick-
Amp Labeling Kit (Agilent Technologies). Labelled cRNA samples (n= 24 in total) were 
hybridized to Agilent Gene Expression Microarray 4x44k slides for 17h at 65°C and treated 
according to the Agilent protocol. The microarrays were scanned using the Agilent High 
Resolution G2565CA Microarray Scanner System. Agilent single-channel microarrays were 
processed using an in-house R-script which integrates the package limma (Smyth, 2005) for 
quality control, normalization and gene differential expression assessment. For each 
microarray, we applied a background correction (Ritchie et al., 2007) using normexp-saddle 
(Ritchie et al., 2006; Silver et al., 2009). For replicated probes on the same array, we replaced 
the individual value with the respective average. For array comparability, we performed 
quantile-normalization (Bolstad et al., 2003). Differentially expressed genes were identified by 
a linear modeling approach and the empirical Bayes statistics (Smyth, 2004). 
 
Quality of the assembly - supplementary results 
The quality of the Hydra transcriptome was made based on statistics such as the ExN50 value 
and the number of genes longer than 1kb. Transcriptome completeness regarding gene content 
was assessed as a complementary approach. The transcriptome was tested for the presence or 
absence of a list of conserved orthologous genes. The BUSCO (Benchmarking Universal 
Single-Copy Orthologs) library of Metazoa orthologous genes was used (Simão et al., 2015). 
This library represents a collection of 843 well-annotated and conserved single-copy metazoan 
orthologs. 
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In total, 730 (86.6%) complete BUSCO hits were obtained, and duplicate hits to 143 (17%) 
genes. Another 45 (5.3%) were fragmented and 68 (8%) were missing. In theory, duplicates 
represent gene duplication and/or mechanisms such as alternative splicing in the sample. 
Indeed, duplicates were high in our total assembly; therefore, this could be explained by the 
expression of paralogs and/or isoforms in the different Hydra’s body plan (foot, body, and 
head). However, the high number of complete genes provides an important validation of the 
depth and completeness of the assembly. 
 
D. mela Ref C:98% [D:6.4%], F:0.6%, M:0.3%, n:2 675 
D. mela busco C:99% [D:3.7%], F:0.2%, M:0.0%, n:2 675 
C. eleg Ref C:85% [D:6.9%], F:2.8%, M:11%, n:843 
C. eleg busco C:90% [D:11%], F:1.7%, M:7.5%, n:843 
H. sapi Ref C:89% [D:1.5%], F:6.0%, M:4.5%, n:3 023 
H. sapi busco C:99% [D:1.7%], F:0.0%, M:0.0%, n:3 023 
L. giga Ref C:89% [D:2.3%], F:4.3%, M:5.8%, n:843 
L. giga busco C:90% [D:13%], F:7.8%, M:2.1%, n:843 
A. nidu Ref C:98% [D:1.8%], F:0.9%, M:0.2%, n:1 438 
A. nidu busco C:95% [D:7.3%], F:3.8%, M:0.9%, n:1 438 
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Figure 2.1. General approach followed to investigate Hydra boundaries. A. Transgenic Hydra 
used to visualize the head boundary. B. Regionalization of Hydra body. The arrows show the 
constant passive movements of the cells due to constant proliferation of stem cells in the body 
column. C. Collection of datasets used in this study. D-E. Examples of some genes in Hydra 
showing a position restricted expression. The dashed lines indicate the concerned boundary. 
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Figure 2.2. Identification of region-specific genes by comparative transcriptomics. A. RNA 
sequenced samples from Hydra body parts plotted in a principal component analysis. B. 
Correlation circle. The higher contributors to the variation from the PCA where plotted and 
annotated, the functional processes are shown in the direction where they contribute from the 
center of the PCA. C. Graphical representation of DEGs annotated by Gene Ontologies where 
the differential expression was at least of 2 fold among the parts. D.DEGs organized in clusters 
according to their expression in the different part of the body. Here we show 4 models of the 
clusters we selected for the analysis. TH: Genes expressed mostly in the Tentacle- Head region. 
F: Genes expressed specifically in the foot region. THF: Common genes expressed in 
differentiated tissue (tentacles, head and foot), and B: Genes overexpressed in the body column.  
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Figure 2.3. Summary of the unbiased RNAseq approach to identify compartment specific 
functional groups of genes. Group of clusters sharing similar expression pattern (Figure 2D) 
were annotated using KEGG pathways to identify the function and biological processes 
dominating in each body part. The colors correlate with the group of clusters from Figure 2,D. 
Notice that members a single pathway can be expressed in a different fashion according to the 
position in the Hydra body axis.  
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Figure 2.4. Changes in the transcriptional landscape upon TSA treatment. D: PCA form all the 
samples in the microarrays assay E. Correlation circle. The higher contributors to the variation 
from the PCA where plotted and annotated, the functional processes are shown in the direction 
where they contribute from the center of the PCA. The organization of the genes in clusters 
according to their expression in the different treatments gave rise to 2 main clusters. F: cluster1, 
where genes that in the control (head DMSO) are downregulated in the head, after TSA 
treatment are upregulated like in the body.  G. cluster 6, here the genes that normally are 
upregulated in the head, after TSA treatment show downregulation to a level as they are 
expressed in the body. 
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Figure 2.5. A higher expression of cell cycle genes is identified in head tissue when Hydra is 
treated with TSA. A. The genes from cluster 1 were annotated by blast and analyzed in the 
KEGG pathway database, here we show the cell cycle pathway. Gene expression pattern along 
the body axis and their change upon TSA treatment is shown in different colored boxes 
according to the legend below. The boxes without color correspond to genes that were either 
not giving a Blast hit or that were falling out in the signal cleaning process. Notice that most of 
the red colored boxes which correspond to genes expressed in the body compartment are also 
with a skin color, meaning that many genes whit restricted expression to the body, are also 
sensible to TSA and change their expression pattern: they are also upregulated in the head upon 
TSA treatment. B-D: TSA treatment leads to BrdU labelled s-phase cells in head tissue in 
differentiated cells. Whole mount BrdU labeling with a lapse of 4 days incubation in DMSO 
(B), TSA 5nM (C) or TSA 10nM (D), with one time feeding and followed by 2 hours incubation 
in BrdU. The arrows show positive BrdU nuclei. Notice that in TSA treatments these nuclei are 
increased in the head and appear in the tentacles where they never did in the control. E-H: TSA 
allows cell to express the stem cell specific transcription factor FoxO. E: reporter construct used 
to check the expression pattern in living animals. The expression of foxO is concentrated in the 
body region of the ectodermal cells (GFP positive region). F: DMSO, G: transgenic animals 
kept 4 days in 5nM TSA, notice that ectodermal cells from head and foot are GFP positive. H: 
transgenic animals kept 10 days in 5nM TSA, notice that the detachment of the bud is disturbed. 
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Figure 2.6. TSA treatment prevents the cells in the head expressing organizer genes. A: Here 
we show some genes belonging to cluster 6. The genes were annotated by blast and organized 
in KEGG categories. Their comparative expression according to the localization in the body 
axis is shown in different colored boxes according to the legend above. The boxes without color 
correspond to genes that were either not giving a Blast hit or that were falling out in the signal 
cleaning process. Notice that the Wnt proteins which are expressed specifically in the head 
(Blue), are also sensible to TSA been downregulated (see also figure 5, D). B-D: Model of 
action of a persistent histone hyperacetylation state in Hydra. Transition of a normal pattern 
into an extended stem cell compartment and a concurrent reduction of the differentiated 
compartments (most notorious in the tentacles). B: Hydra in normal conditions or in DMSO. 
C: After 2-3 days incubation in TSA 2.5nM. D: After 2-3 days incubation in TSA 10nM. 
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Figure 2.7. Histone deacetylation model: A. Histone deacetylation by HDACs (Millard et al., 
2017, 2013b) leads conventionally to the inhibition of gene expression  (Struhl, 1998) and the 
first compaction step of chromatin (Eskeland et al., 2010).  B. TSA inhibits HDACs and leads 
to a histone hyperacetylation state, thereby many genes cannot be silenced. C. In Hydra, 
increased expression of members of the phosphatidylinositol signaling system and inositol 
phosphate metabolism pathways in differentiated tissue (head and foot) results in numerous 
phosphatidylinositols (PI) and soluble inositol phosphate isoforms which cause  fully 
activation of HDACs in complex (see Watson et al., 2016). D. Exposure of Hydra polyps to 
low dose of TSA hampers the differentiation process, interferes with the maintenance of the 
boundary and results in a transition of the whole body into a stem cell compartment.  E. 
Drosophila embryos of mutant Rpd3 (HDAC 1/2 in Drosophila melanogaster) germline clones 
display a drastically disturbed segmentation phenotype (Mannervik and Levine, 1999; Perrimon 
et al., 1996). F.  A similar effect of TSA is seen on the Root Apical Meristem (RAM) from 
Arabidopsis thaliana. HDACs inhibition causes an increase in meristem size without increase 
in cell division which has been interpreted as a delay of differentiation (Rosa et al., 2014), 
suggesting that controlling the level of histone acetylation is fundamental for the timely 
transition into differentiation (Ikeuchi et al., 2015). Acetylation representation modified from 
(Morao et al., 2016). 
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Abstract 
Despite enormous research efforts, the genetic component of longevity has remained largely 
elusive. Since the investigation of common variants, mainly located in intronic regulatory 
regions in the genome, has yielded only little new information on the longevity heritability, we 
performed a chip-based exome-wide association study focusing on both common and rare 
variants in our German longevity cohort comprising more than 1,200 long-lived individuals, 
including 599 centenarians. In a single-variant analysis, we found rs1046896 in the gene 
fructosamine-3-kinase-related-protein (FN3KRP) to be significantly associated with longevity. 
An eQTL database search revealed the rs1046896 longevity allele to be associated with higher 
gene expression in various human tissues. A gene-based analysis, in which potential collective 
effects of common and rare variants were considered, yielded the gene phosphoglycolate 
phosphatase (PGP) as another potential longevity locus. With both the single-variant and the 
gene-based analysis, we validated previously reported longevity associations, i.e. for CDKN2B 
(rs1063192) and OTOL1, respectively. Replication of our results in French and Danish 
longevity collections, was successful for rs1063192 in the French; the longevity-association 
was further substantiated by a meta-analysis. 
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3.1. Introduction 
Human longevity is a complex phenotype influenced by both genetic and environmental factors, 
which furthermore interact, e.g., via epigenetic changes [1]. Heritability estimates for longevity 
range from 12% [2] to 30% [3]; however, in the oldest-old, the genetic influence is even higher 
(up to 48%) [4]. Candidate studies have yielded many potential longevity associations, but most 
of them could not be replicated in independent investigations. To date, variation in only four 
loci has been confirmed to impact longevity across populations: APOE [5, 6], FOXO3 [7, 8], 
the 5q33.3 locus [9, 10] and CDKN2B [11–13]. The first three reached genome-wide 
significance in large genome-wide association studies (GWAS) [9, 14]. However, the identified 
variants together only explain a small proportion of the longevity heritability. Thus, novel 
approaches are needed to identify additional loci involved in the phenotype. 
 
Longevity studies have mostly been conducted following the common disease/common variant 
hypothesis, which is based on the assumption that the likelihood of becoming long-lived 
depends on a small number of single nucleotide variants (SNVs) that occur at high frequency 
in all populations. Yet, it has been estimated that common variants explain only 5 - 10% of the 
heritability of complex traits [15–17]. Rare variants may contribute a considerable fraction to 
the heritability of complex traits, i.e. according to initial estimates, half the heritability 
explained by common SNVs [18]. Therefore, rare variants may substantially regulate longevity, 
but they are often not covered by genome-wide genotyping arrays or imputations [14]. Common 
variants often reside in regulatory/intronic regions [19], and GWAS SNPs for complex traits 
are enriched in functionally important intronic regions [20]. However, rare variants in or near 
coding regions are thought to have larger effects on the trait of interest than rare or common 
regulatory variants [19]. To date, only in a few longevity studies, the coding regions of the 
genome have been targeted or covered, e.g. by the application of exome-based genotyping [21] 
or whole-genome [22] or exome-sequencing [23–27]. These approaches yielded important 
results, not only in terms of new longevity variants (e.g. mutations in CLEC3B and HLA-DQB1 
[21, 26]); they also provided novel analysis methods that could extend the discovery spectrum 
of loci and genes influencing complex traits (e.g. analysis for an accumulation and/or 
combination of multiple variants) [11, 28]. 
 
Here, we performed an exome-wide association study (EWAS) in a large German longevity 
cohort comprising more than 1,200 centenarians and nonagenarians. We used the Illumina 
Infinium HumanExome BeadChip that covers both rare and common variants. In a single-
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variant analysis, we found rs1046896, located in the gene fructosamine-3-kinase-related-
protein (FN3KRP), to be significantly associated with longevity. An eQTL database search 
revealed the rs1046896 longevity allele to be associated with higher gene expression in various 
human tissues. We furthermore performed a gene-based analysis to consider potential collective 
effects of individual common and rare variants. This analysis yielded, next to FN3KRP, the 
gene phosphoglycolate phosphatase (PGP) as a potential longevity locus. With both the single-
variant and the gene-based analysis, we validated previously reported longevity associations, 
i.e. for CDKN2B (rs1063192) and OTOL1, respectively. Replication of our results in French 
and Danish longevity collections was successful for rs1063192 in the French; the longevity-
association was further substantiated by a meta-analysis. By considering SNV-SNV 
interactions, we were able to define a functional context highlighting the relevance of Tie2, 
PI3K/AKT and mTOR signaling, as well as calcium mobilization in healthy aging and 
longevity. 
 
3.2. Results 
3.2.1. Single-variant association analysis reveals a longevity association of rs1046896 in 
FN3KRP  
To identify new common and rare genetic variants with moderate to high penetrance associated 
with longevity, a chip-based EWAS was conducted using the Illumina Infinium HumanExome 
BeadChip (Figure 3.1). This array covers rare and common variants in a ratio of approximately 
rare:common = 8:1 [29]. In total, 1,248 German LLI and 6,941 younger controls were included 
in the study. The genotyping analysis was performed based on 62,488 SNVs, and 1,212 LLI 
and 6,762 younger controls, which had remained after QC (Supplementary figure 1, 
Supplementary figure 2). The single-variant association approach yielded 11 candidate SNVs 
(P < 1 x 10E-04) (Table 3.1, and Supplementary figure 3). Among the associated variants, 
we identified rs2075650, rs4420638, and rs769449 located in the 
TOMM40/APOE/APOC1region, a region that is well known to be negatively associated with 
longevity [5, 9, 11, 30]. Apart from these SNPs, the best association signal was obtained for 
rs1046896 in the gene FN3KRP (minor allele frequency (MAF) = 0.32, P = 7.40 x 10E-07; 
Table 3.1), which passes the exome-wide association significance threshold of 1 x 10E-06 for 
common variants [31]. In addition, we observed a longevity association for rs1063192 in the 
CDKN2B-AS1 region (2.99 x 10E-05; Table 3.1), which has previously been reported in the 
context of human longevity [11]. 
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The effects of the candidate variants were investigated for independency of the 
TOMM40/APOE/APOC1 locus by a conditional association test. The results of the conditional 
analysis confirmed the associations of rs1046896 (FN3KRP), rs55882518 (NOTCH3), 
rs1063192 (CDKN2B-AS1 region), rs1319846 (TMEM131L) and rs1790706 (DSC2) with 
longevity (Table 3.1). Additionally, an association analysis with the centenarian subpopulation 
(n=599 individuals ≥100 years) was performed. Although the centenarian subset comprised 
substantially fewer individuals, the association analysis yielded higher ORs for rs1046896 
(FN3KRP), rs55882518 (NOTCH3), 1063192 (CDKN2B-AS1 region) and rs184214819 (SPZ1) 
(Supplementary table 2). This effect has been reported before [32], and is consistent with the 
greater genetic influence with increasing age. 
 
Since we had noticed that our best-associated new candidate longevity SNV rs1046896 was 
located in a 3'UTR region and might therefore have structural implications for the mRNA 
stability [33]. (i.e. might affect gene expression in an allele-dependent manner), we investigated 
whether this SNV or SNVs in high LD (r2 > 0.8 based on HapMap-CEU individuals; 1,000 
Genomes phase 3 [34, 35]) influences local or distant gene expression. Using the publicly 
available databases Blood eQTL browser (https://genenetwork.nl/bloodeqtlbrowser/) [36] and 
the GTEx eQTL database (https://www.gtexportal.org/home/, accessed April 5 2019), we 
observed significant cis-eQTL associations of rs1046896 (and high-LD SNVs) with its vicinity 
genes, especially with the expression of FN3KRP and FN3K in several tissues (e.g. brain 
regions, testis, pancreas; Supplementary table 3). For all reported tissues, FN3KRP gene 
expression was higher in the presence of the rs1046896 longevity allele C (major allele) 
(Supplementary table 3, Supplementary figure 4). 
 
3.2.2. The longevity-association of rs1063192 (CDKN2B) replicates with borderline 
significance in an independent cohort  
We aimed for replication of the association results in two independent cohorts. Sample sizes of 
the Danish and French cohorts (Danish: 1,002 LLI, 737 younger controls and French: 1,264 
LLI and 1,830 younger controls) limited the replication approach to the common variants 
rs1046896 (FN3KRP), rs1063192 (CDKN2B), and rs1319846 (TMEM131L). The association 
of rs1063192 (CDKN2B) reached borderline significance in the French (P = 0.056, OR = 1.14; 
Table 3.2), but not in the Danish (P = 1.00, OR = 1.04; Table 3.2). The other SNPs did not 
replicate, either in the French or in the Danish (Table 3.2). 
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In a meta-analysis, we observed large inconsistency (I2) of the genetic effects across the three 
studies (I2 > 75%) for rs1046896 (FN3KRP) and rs1319846 (TMEM131L), but moderate I2 (25 
> I2 <75%) for rs1063192 (CDKN2B) (Table 3.2). The between-population heterogeneity of 
the genetic effects for rs1063192 (CDKN2B) was estimated as 40.72% (Table 3.2). To 
overcome a potential heterogeneity bias, we used the random effects summary odd ratio 
(OR(R)). The strongest evidence for an association with longevity was observed for rs1063192 
(CDKN2B) (OR(R) = 1.14, P = 0.00174; Table 3.2). The association for this SNV (or others in 
high LD like rs4977756) had been already replicated previously by others [11–13], however, 
in the Danish sample, we could not detect any association with longevity. Both the slightly 
smaller sample size (1,003 cases compared with 1,248 cases in the German and 1,264 cases in 
the French cohort) and the older age of the Danish (< 71 years) compared with the German (< 
60 years) or French (< 62 years) controls might have contributed to the missing replication. 
 
3.2.3. Gene-based analysis reveals PGP as a potential new longevity locus and strengthens 
the FN3KRP association 
In addition to the single-variant association approach, we assessed the cumulative effects of 
common and rare variants within one genomic region. In the gene-based association test, 13 
genes (apart from TOMM40/APOE/APOC1) were identified with an enriched burden of rare 
and common variants (P < 1 x 10E-04). However, only PGP survived Bonferroni correction in 
both the SKATO and the burden test (Table 3.3). Of the 13 genes, four (FN3KRP, GRN, 
SKOR1, SPZ1) had already been observed in the single-variant association analysis. With the 
gene-based analysis, we validated the previously reported association of OTOL1 with human 
longevity (rs1425609; [37]). In the present work, OTOL1 reached a P-value < 1.61 x 10E-06 in 
the burden test. An association analysis using the centenarian subset only, yielded significant 
associations (P < 3 x 10E-06) for seven genes (apart from APOE) that survived Bonferroni 
correction (Supplementary table 4). Of these seven genes, FN3KRP and HMHA1 overlapped 
with the gene-based analysis using the whole German study population. The remaining five 
genes (TMEM14A, IRAK1BP1, ACPP, PLXNB1, and GAR1) were identified in the centenarian 
subpopulation only (Supplementary table 4). 
 
3.2.4. SNV-SNV interaction analysis reveals a functional longevity framework 
To extend the understanding of the complex biology of longevity, we performed a SNV-SNV 
interaction analysis. A total of 52,310 SNVs (all SNVs from the array apart from those in 
linkage disequilibrium (LD) and those on the gonosomes) were used to test all possible 
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interactions with SNPsyn [38] without a priori hypothesis. For 86 SNVs, we found 148 
significant interacting pairs with positive synergy, i.e. each SNV conveys non-redundant 
information (Supplementary table 5). The genes annotated to the 86 SNVs and those 
annotated to the significantly associated SNVs from the association analyses (in total, 90 core 
genes) were uploaded to GeneMANIA [39] and ClueGo [40] to predict their functional 
implications. Based on the genome-wide map of human genetic interactions published by Lin 
et al. [41], GeneMANIA confirmed most of the interactions generated with SNPsyn 
(Supplementary figure 4), Additionally, GeneMANIA predicted 20 genes to be functionally 
related to the 90 core genes (Supplementary table 6). From the whole set of 110 genes, a 
functional map of longevity was generated using ClueGo that comprised seven functional 
groups (RNA modification; regulation of cholesterol transport; role of LAT2 on calcium 
mobilization; insulin receptor pathway; IGF1R signaling cascade; Tie2 signaling, Figure 3.1 
and Supplementary table 7). 
 
3.3. Discussion 
In our large German longevity cohort comprising more than 1,200 LLI (incl. ~600 
centenarians), we screened 62,488 common and rare exonic SNVs for an association with 
longevity. We discovered rs1046896 in the 3'UTR region of the gene fructosamine-3-kinase-
related-protein (FN3KRP) as a novel longevity-associated variant that reached exome-wide 
significance. Additionally, we replicated the longevity-association of rs1063192 in CDKN2B-
AS1 [11] as well as rs2075650, rs4420638, and rs769449 in the TOMM40/APOE/APOC1 region 
[9, 11]; the latter three are well known for being both negatively associated with longevity and 
positively associated with Alzheimer's disease [6, 42]. 
 
Our meta-analysis, which included data from our German cohort as well as from French and 
Danish sample collections, revealed very high between-population heterogeneity for rs1046896 
in FN3KRP. This might indicate that the identified SNV is not the causal variant and shows 
different LD patterns with the causal polymorphism in the three populations included in the 
meta-analysis [43]. However, based on the eQTL prediction analysis (Supplementary table 3, 
Supplementary figure 4), rs1046896 and SNVs in high LD appear to influence the stability of 
FN3KRP and thereby regulate its expression. In future studies, a fine-mapping of the FN3KRP 
gene region is needed to identify the causal variant. 
 
FN3KRP belongs to a gene family with an important role in the reversal of the non-enzymatic 
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glycation of proteins [44]. Glycation adversely affects protein function, which leads to arterial 
stiffening [45] in particular and to an accumulation of damaged proteins. This in turn promotes 
aging [44] and the development of age-related diseases [46]. Both FN3RKP and fructosamine-
3-kinase (FN3K), which show 65% sequence similarity, seem to protect proteins from non-
enzymatic glycation and to stop the formation of certain advance glycation end products [44, 
47]. Strikingly, rs1046896-T, which showed a lower allele frequency in the LLI in our study 
(ORcond. = 0.77; ORcond._centenarian = 0.70), was identified as a risk locus for glycated 
hemoglobin (HbA1c), a critical non-enzymatic glycation product used to monitor and diagnose 
diabetes [48]. Our findings, together with the substantial role of FN3KRP in cell maintenance 
and viability, support it as a promising candidate which may facilitate healthy aging and 
longevity by preventing physiological deterioration. 
 
Interestingly, rs1063192-G in the CDKN2B region, which was enriched in the LLI of our 
sample and whose longevity-association was further supported by our meta-analysis, was 
reported to be a protective variant in glaucoma, a classical age-related disease [49], which is 
also characterized by an increased burden of advanced glycation end products [46]. 
 
Apart from rs1046896 (FN3KRP), rs1063192 (CDKN2B-AS1), and rs2075650, rs4420638, and 
rs769449 (TOMM40/APOE/APOC1), six additional SNVs showed an association with 
longevity (P < 2 x 10E-04, Table 3.1). We found exome-wide significant (EWS) associations 
only for the three variants in the TOMM40/APOE/APOC1 region and rs1046896 (FN3KRP). 
However, variants without EWS (or genome-wide significance) may still reflect true 
association signals with biological relevance. It was shown that eight of the ten top CHARGE 
SNVs without GWS from a meta-analysis of GWAS [30], correspond to mouse lifespan 
quantitative trait loci (QTL) [50]. Of the 11 SNVs, for which we report a longevity association, 
four represented rare variants (MAF < 0.05%, Table 3.1). In a recent study, in which the 
exomes of 100 LLI were sequenced, no rare protein-altering SNV was observed to be enriched 
in the genomes of the LLI compared to younger controls [27]. However, our results show that 
rare coding variants may be drivers of longevity. 
 
Studies on other complex traits have shown that gene-based tests, in which all common and 
rare SNVs within a gene locus are considered jointly, can be more powerful than single-variant 
association approaches. When we examined the cumulative effect of common and rare variants 
within each gene, we discovered PGP (cumulative effect of three variants: two rare and one 
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common) as another novel longevity-associated locus (P = 8.90 x 10E-07). Via its function as 
glycerol-3-phosphate (Gro3P) phosphatase, PGP controls the levels of Gro3P, which is an 
important metabolite formed during glycolysis [51]. The availability of Gro3P is crucial for the 
regulation of both glucose and fat metabolism and eventually determines the generation of 
signaling and regulatory molecules, which further affect many biological processes (e.g., 
insulin secretion and sensitivity, inflammation, fat synthesis and storage, (cancer) cell 
proliferation) [52]. Therefore, PGP may aid in the detoxification of excess nutrient/fuel 
supplies, thereby preventing metabolic stress with its associated pathologic conditions, e.g. type 
2 diabetes, cardiovascular diseases and metabolic syndrome [52–54], and eventually facilitating 
longevity. 
 
In the gene-based test, apart from PGP and TOMM40/APOE/APOC1, we identified 17 
additional potential longevity genes (P < 1 x 10E-04), including otolin 1 (OTOL1). One intronic 
SNV in OTOL1, rs1425609, has already been associated with longevity in a single-variant 
analysis in a previous study [37]. The fact that the gene-based test led to the replication of a 
longevity-association, whose identification was based on a single variant, not only validated 
the gene-based approach, but also points towards the added value of analyzing both common 
and rare SNVs jointly for explaining the missing longevity heritability. Next to OTOL1, the 17 
genes included the ribosomal protein S6 kinase B1 (RPS6KB1), a downstream effector of the 
nutrient-responsive mTOR (mechanistic target of rapamycin kinase), which was shown to 
promote longevity in yeast, worms, and flies [55]. Furthermore, TMEM14A, IRAK1BP1, ACPP, 
PLXNB1, and GAR1, all involved in cell proliferation and cell growth [56–60], also reached 
nominal statistical significance. Noteworthy, the gene FN3KRP reached a P-value of P = 3.08 
x 10E-06 and survived multiple testing correction in the centenarians subset (Supplementary 
table 4). This supports the FN3KRP-longevity association to be a true-positive signal. An 
accumulation of common and rare variants has already been observed in genes associated with 
other complex traits like type 2 diabetes [61] and Alzheimer´s disease [42]. With respect to 
extreme aging, the genes LYST, MDN1 and RBMXL1 were found to harbor an increased burden 
of rare coding variants in LLI versus younger controls; however, with nominal significance 
only [27]. To our knowledge, joint effects of common and rare variants on human longevity 
have not been investigated yet in a cohort of comparable size like ours. In a recent study, sets 
of variants with low and rare frequency (MAF< 0.05) were analysed for an association with 
longevity in East Asians (530 nonagenarians/centenarians). More than 100 genes reached 
nominal significance in that study; however, EWS was not met by any of the genes [21] and we 
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could not identify an overlap with our results. 
 
SNV-SNV interaction analysis predicted genetic interactions between 86 genes that, together 
with the longevity-associated genes annotated to the significant SNPs from the association 
analyses in the present work, may depict the molecular and physiological pathways underlying 
human longevity. The functional network of the longevity-associated genes identified in this 
study tended to form hubs, which were determined rather by co-expression and genetic 
interaction data than by co-localization or physical interaction (Supplementary figure 4). 
Overall, our functional network supported previous reports on pathways that likely control 
longevity, i.e. the mTOR and insulin/IGF1 signaling pathways [55, 62]. Tie2 signaling has been 
suggested to be indispensable for neovascularization and protection of age-related macular 
degeneration and glaucoma [63, 64], which is in concordance with our findings for rs 1063192 
and FN3KRP. Telomere maintenance has also been suggested to be crucial for attaining 
longevity [62]. In our functional network, the genes GAR1 and NAT10, both involved in rRNA 
modification, were reported to be telomerase-associated proteins, and particularly over-
expression of NAT10 was shown to induce telomere shortening [65]. 
 
3.4. Conclusion 
With our study, we contribute to the genetic framework of longevity with two new potential 
candidate genes, FN3KRP and PGP, which were identified by single-variant and gene-based 
analyses, respectively. The two genes influence longevity likely by their role in metabolic 
processes, i.e. the reverse glycation of proteins (FN3KRP) and control of Gro3P levels (PGP). 
However, with respect to FN3KRP, the variant that we report here (rs1046896) is unlikely to 
be the causal variant, considering the high between-population heterogeneity values in the 
meta-analysis of the German, Danish and French association results. Future fine-mapping 
studies are warranted to identify the true functional variant in high LD with rs1046896. With 
the combination of analysis methods and, in particular, the investigation of cumulative effects 
of common and rare variants within one genetic region, we are a step closer to accounting for 
the missing heritability of human longevity. 
 
3.5. Materials and methods 
German, Danish and French study populations 
The German sample comprised 1,248 German LLI (male/female ratio: approximately 1/3; age 
range: 94 - 110 years; mean age: 99) as described previously [6, 8]. Briefly, the control sample 
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contained 6,941 younger individuals (age < 60 years) from a German population-based 
collection recruited with the help of the biobank popgen; in detail, 2,905 adults from the KORA 
study (Collaborative Health Research in the Region of Augsburg) [66], 2,360 individuals from 
HCDEBONN, 998 Germans from the popgen biorepository [67], 473 participants from 
HCDEMICK, and 205 additional individuals from HCGCON. All study participants provided 
a written informed consent prior to enrolment in the study. Approval for the project was 
obtained from the Ethics Committee of the Medical Faculty of Kiel University. 
 
For the Danish data set, the 1,003 cases (male/female ratio 1/3, age range: 91 - 101 years) 
consisted of participants drawn from seven nation-wide surveys collected at the University of 
Southern Denmark; the Study of Danish Old Sibs (DOS), the 1905 Birth Cohort Study, the 
1910 Birth Cohort Study, the 1911-12 Birth Cohort Study, the 1915 Birth Cohort Study, the 
Longitudinal Study of Danish Centenarians (LSDC), and the Longitudinal Study of Ageing 
Danish Twins (LSADT). Briefly, DOS was initiated in 2004 and included families in which at 
least two siblings were ≥ 90 years of age at intake. The LSDC and 1905, 1910, and 1915 Birth 
Cohort Studies were prospective follow-up studies initiated in 1995, 1998, 2010, and 2010, 
when participants were 100, 92-93, 100, and 95 years of age, respectively  [68]. The 1911-
1912 Birth Cohort Study consisted of individuals reaching the age of 100 years in the period 
from May 2011 to July 2012 [69] and LSADT was initiated in 1995 and includes Danish twins 
≥ 70 years of age [70]. From DOS and LSADT, one individual from each sib-ship or twin pair 
was randomly selected among participants that had reached an age of ≥ 91 years for DOS, and 
≥ 90 years for LSADT. From the 1905 and 1915 Birth Cohort Studies, participants were 
selected among individuals reaching an age of minimum 96 years. The 1,189 controls (age < 
71 years) consisted of individuals recruited by the Danish Twin Registry (DTR) as part of the 
study of Middle-Aged Danish Twins (MADT). MADT was initiated in 1998 and included 4,314 
twins randomly chosen from each of the birth years 1931-1952 [71]. Surviving participants 
were revisited from 2008 to 2011 [72], where the blood samples used for DNA extraction were 
collected. Signed informed consents were obtained from all participants. Collection and use of 
biological material and survey information were approved by the Regional Committees on 
Health Research Ethics for Southern Denmark, and the study was approved by the Danish Data 
Protection Agency. 
 
The French data set comprised 1,264 individuals (male/female ratio ~ 1/4.5, mean age 102.4 
years; age-range 91-115+ years) [73]. French siblings were recruited when at least two siblings 
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fulfilled the age criterium of 90 years or older; in such a case the oldest sibling was selected for 
the study. All subjects signed a written informed consent form in accordance with the local 
review board. The French controls consisted of 1,830 subjects (age < 62 years) selected in a 
population-based sample of French subjects that had participated in the Supplementation in 
Vitamins and Mineral Antioxidants (SU.VI.MAX) study [74]. 
 
Exomechip genotype calling and quality control 
Study samples were genotyped on the BeadChip Illumina HumanExome-12v1.1 (N = 244,770 
SNVs) or BeadChip Illumina HumanExome-12v1.2 (N = 247,870 SNVs) (Illumina Inc., San 
Diego, USA). Genotype calling was performed using the GenomeStudio software and the 
GenTrain v2.0 clustering algorithm (Illumina Inc., San Diego, USA). To improve genotype 
calling, zCall software v3 [75] and call rate > 95% was used. In order to avoid false positive 
associations, an independent quality control (QC) was performed for samples and SNVs. QC 
was done with the software Plink 1.9 [76]. In total, 224 samples were removed because they 
had failed one or more of the following inclusion criteria: discordant sex information, missing 
genotype < 3%, heterozygosity rate greater or lower than ± 4sd from the mean, and no 
relatedness of individuals. Relatedness was estimated using identity by descent metric (IBD) 
[77]. For related individuals (IBD > 0.1875; halfway between the expected IBD for third- and 
second-degree relative [77], only one individual was included in the analysis. SNVs were 
excluded if the missing rate was too high (> 3%) or, for common SNVs in the control sample, 
if they deviated from Hardy-Weinberg equilibrium (P < 0.0001). Due to the lack of sufficient 
statistical power, SNVs with extremely low minor allele frequency (MAF < 0.003, equivalent 
to a minor allele count (MAC) ≥ 21) were removed. Power calculations were carried out with 
the Gas Power Calculator 
(http://csg.sph.umich.edu/abecasis/cats/gas_power_calculator/index.html). For the single-
variant analysis, the Bonferroni-corrected P-value threshold was based on the number of 
markers tested: P < 8 x 10E-07 (significance threshold 0.05/62,488 number of markers tested). 
Concordantly, the gene-based Bonferroni-corrected P-value threshold was based on the number 
of gene sets tested: P < 3.3 x 10E-06 (significance threshold of 0.05/14,790 gene sets). 
 
Prior to further analysis, a confounder correction was conducted based on gender, linkage 
disequilibrium (LD) and population stratification. Population substructure was evaluated with 
the principal component analysis (PCA) using a common set of independent markers (N = 
16,782 SNVs). The principal components (PC) were calculated using PLINK 1.9 [76], and the 
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first five PCs were selected to identify potential confounders for the correction. Additionally, 
stratification outliers were identified based on the local outlier factor (LOF > 1.7) [78] and 
excluded to mitigate population stratification. 
 
Association analysis in the German sample 
Single-variant association analysis was performed using the logistic regression test 
implemented in PLINK1.9 [76], assuming an additive genetic model. Candidate longevity 
SNVs with a discovery P-value < 1 x 10E-04 were selected for replication. This threshold is 
less stringent than 1 x 10E-06 which was proposed for EWAS [31]. Relaxation in the selecting 
threshold allows the identification of longevity SNVs which usually have small effects on the 
phenotype [79]. To identify additional association signals and to test for independency of the 
newly identified SNVs from the effects of the known longevity-associated locus 
TOMM40/APOE/APOC1 [9, 11, 30], a conditional association test was performed considering 
the SNVs rs2075650, rs4420638, and rs769449. The conditional test was done using the logistic 
regression test in PLINK1.9 [76]. The genomic inflation was estimated based on the P-values 
of the association. The Sanger imputation service 
(http://www.sanger.ac.uk/science/tools/sanger-imputation-service) and the 1000 Genomes 
phase I v.3 reference panel was used to enrich the common SNV pool. 
 
In addition to the single-variant association testing, a gene-based analysis was performed. 
Potential cumulative effects of rare and common variants with longevity were tested using both 
burden and non-burden (i.e. SKAT) approaches from the algorithm RC-SKAT [80]. Both 
approaches were considered because burden tests were shown to perform better if multiple 
variants in the regions are causal and influence the phenotype in the same direction [81], while 
non-burden tests, like SKAT [82], are more advantageous if SNVs in the region interact or 
show opposing directions of effect [83]. From the 244,770 SNVs on the HumanExome-v12 
BeadChip, a gene-set file was prepared using the R-package biomaRt [84]. The overall effect 
of rare and common variants in a gene was evaluated based on the adaptive sum test [80] in 
combination with either burden or SKAT. 
 
Synergistic effects among SNVs were assessed using SNPsyn [38]. SNPsyn uses an 
information-theoretic approach for a synergistic interaction analysis. A synergy between a pair 
of SNVs is measured as the difference between the information of the SNV-SNV phenotype 
and the sum of the information encoded by the two individual SNVs [38]. Shared information 
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(depicted in the information score) between SNV pairs can be either positive (synergistic SNVs) 
or negative. If negative, the two SNVs carry redundant information; an effect that is frequently 
observed among highly correlated SNVs. The significances of the information scores were 
calculated using permuting genotype data across samples 500 times. The scores were corrected 
for multiple testing using false discovery rate (FDR) [85]. SNV interactions were considered 
significant if the corrected P-value < 0.001. 
 
The list of core genes (annotated to SNVs from both the SNV-SNV interaction analysis and 
association analyses) was used together with GeneMANIA Cytoscape plugin (under default 
parameters) [39] to enrich the functional context of the gene-associated candidates. 
GeneMANIA uses a network weighting approach to determine how genes in a gene list are 
connected to one another or for determining which types of functional or genomic data are the 
most useful to collect for finding more genes like those in the query list [86]. Later, functional 
annotation was performed in the context of the Gene Ontology (GO) terms [87], KEGG [88] 
and REACTOME [89] pathways using ClueGo Cytoscape plugin [40]. ClueGo creates first a 
binary gene-term matrix using gene's annotations, similar as descried by Huang et al. [90]. GO 
terms and pathways with less than three annotated genes were filtered out. A chance-corrected 
measure of co-occurrence between pair of terms (kappa statistics) was used to determine the 
association strength between terms [91]. Thus, ClueGo creates a network that represents the 
terms as nodes linked based the kappa score level (> 0.3). Functional groups in the network 
were created by iterative merging and those with a corrected (FDR) P-value < 0.05 were 
selected for the representation. 
 
Genotyping in the replication cohorts 
DNA was extracted from dried blood spot cards using either the DNA Mini or Micro Kits 
(Qiagen, Hilden, Germany) or the Extract-N-AmpTM Blood PCR Kit (Sigma-Aldrich, St. 
Louis, MO, USA) followed by amplification using the GenomePlex Complete Whole Genome 
Amplification (WGA) Kit (Sigma Aldrich, St. Louis, MO, USA), or from whole blood using a 
manual [92] or a semi-automatic (Autopure, Qiagen, Hilden, Germany) salting out method. 
 
Danish LLI were genotyped using the Illumina HumanOmniExpress Array (Illumina Inc., San 
Diego, CA, USA). Pre-imputation quality control included filtering of SNPs on genotype call 
rate <95%, HWE P<10-4, and MAF < 1%, and individuals on sample call rate <95%, 
relatedness and gender mismatch. After imputation to the 1000 Genomes phase I v.3 reference 
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panel, genotype probabilities were converted to hard-called genotypes in Plink (using a cut-off 
of 90%) [76]. For the Danish controls, data of the SNPs rs1063192, rs1046896 and rs13119846 
was extracted from quality controlled genotype data created using the Illumina Infinium 
PsychArray (Illumina Inc., San Diego, CA, USA). 
 
French individuals were genotyped by TaqMan (Thermo Fisher Inc., Waltham, Massachusetts, 
USA) on a 7900HT Fast Real-time PCR System (Thermo Fisher Scientific Inc., Waltham, 
USA). Association analysis was performed using logistic regression accounting for gender as 
covariate in the software Stata [93] and Plink [76]. 
 
Meta-analysis was performed with Plink [76]. Fixed and random effect models were used to 
estimate the effect size. Cochran's Q statistics and I2 metric were calculated to measure 
between-study heterogeneity. 
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Tables 
Table 3.1. Association statistics for the 11 longevity-associated SNVs identified by the single-variant association approach in the whole German study population. 
   MAFa   Basic association test  Conditional analysis 
SNV Gene Chr LLI C MA  ORb Pd   ORb Pd  
       [95% C.I.]c   [95% C.I.]c  
rs769449 APOE 19 0.056 0.109 A  0.48 [0.40 - 0.58] 7.77E-15   -   -  
rs4420638 APOC1 19 0.109 0.169 G  0.60 [0.52 - 0.69] 3.55E-13   -   -  
rs2075650 TOMM40 19 0.109 0.147 G  0.70 [0.61 - 0.80] 3.51E-07   -   -  
rs1046896 FN3KRP 17 0.276 0.324 T  0.78 [0.71 - 0.86] 7.40E-07  0.77 [0.70 - 0.85] 2.32E-07 
rs55882518 NOTCH3 19 0.013 0.005 T  2.69 [1.73 - 4.18] 1.07E-05  2.77 [1.78 - 4.30] 6.23E-06 
rs13119846 TMEM131L 4 0.486 0.438 C  1.22 [1.11 - 1.33] 1.73E-05  1.21 [1.11 - 1.32] 2.45E-05 
rs1063192 CDKN2B 9 0.482 0.439 G  1.21 [1.11 - 1.32] 2.99E-05  1.22 [1.12 - 1.33] 1.08E-05 
rs184214819 SPZ1 5 0.009 0.003 A  3.01 [1.77 - 5.11] 4.72E-05  2.79 [1.64 - 4.74] 1.52E-04 
rs200956599 SKOR1 15 0.014 0.006 T  2.34 [1.55 - 3.54] 5.24E-05  2.29 [1.52 - 3.47] 8.65E-05 
rs63750412 GRN 17 0.008 0.002 T  3.57 [1.93 - 6.61] 5.18E-05  3.34 [1.80 - 6.18] 1.29E-04 
rs1790706 DSC2 18 0.159 0.189 A   0.79 [0.70 - 0.89] 9.59E-05   0.78 [0.69 - 0.88] 3.35E-05 
 
APOC1, apolipoprotein C1; APOE, apolipoprotein E; CDKN2B, cyclin dependent kinase inhibitor 2B; DSC2, desmocollin 2; FN3KRP, fructosamine 3 kinase 
related protein; GRN, granulin precursor; NOTCH3, notch 3; SKOR1, SKI family transcriptional corepressor 1; SPZ1, spermatogenic leucine zipper 1; TMEM131L, 
transmembrane 131 like; TOMM40, translocase of outer mitochondrial membrane 40 
Long lived individuals (LLI); controls (C); chromosome (Chr) 
aMinor allele frequency, MAF; the definition of the minor allele (MA) is based on controls 
bOdds ratio for longevity, OR; based on the MA in controls 
c95% confidence interval, 95% C.I.; C.I. for the OR 
dAllelic P-values, calculated with chi - squared test with one degree of freedom 
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Table 3.2. Single-variant replication and meta-analysis statistics for candidate SNVs in the French and Danish populations. 
   MAFa   Basic association test  Conditional analysis 
SNV Gene Chr LLI C MA  ORb Pd   ORb Pd  
       [95% C.I.]c   [95% C.I.]c  
rs769449 APOE 19 0.056 0.109 A  0.48 [0.40 - 0.58] 7.77E-15   -   -  
rs4420638 APOC1 19 0.109 0.169 G  0.60 [0.52 - 0.69] 3.55E-13   -   -  
rs2075650 TOMM40 19 0.109 0.147 G  0.70 [0.61 - 0.80] 3.51E-07   -   -  
rs1046896 FN3KRP 17 0.276 0.324 T  0.78 [0.71 - 0.86] 7.40E-07  0.77 [0.70 - 0.85] 2.32E-07 
rs55882518 NOTCH3 19 0.013 0.005 T  2.69 [1.73 - 4.18] 1.07E-05  2.77 [1.78 - 4.30] 6.23E-06 
rs13119846 TMEM131L 4 0.486 0.438 C  1.22 [1.11 - 1.33] 1.73E-05  1.21 [1.11 - 1.32] 2.45E-05 
rs1063192 CDKN2B 9 0.482 0.439 G  1.21 [1.11 - 1.32] 2.99E-05  1.22 [1.12 - 1.33] 1.08E-05 
rs184214819 SPZ1 5 0.009 0.003 A  3.01 [1.77 - 5.11] 4.72E-05  2.79 [1.64 - 4.74] 1.52E-04 
rs200956599 SKOR1 15 0.014 0.006 T  2.34 [1.55 - 3.54] 5.24E-05  2.29 [1.52 - 3.47] 8.65E-05 
rs63750412 GRN 17 0.008 0.002 T  3.57 [1.93 - 6.61] 5.18E-05  3.34 [1.80 - 6.18] 1.29E-04 
rs1790706 DSC2 18 0.159 0.189 A   0.79 [0.70 - 0.89] 9.59E-05   0.78 [0.69 - 0.88] 3.35E-05 
 
C, younger controls; CDKN2B, cyclin dependent kinase inhibitor 2B; FN3KRP, fructosamine 3 kinase related protein; LLI, long-lived individuals; TMEM131L, transmembrane 131 like. Listed are 
rs-numbers, annotated gene name, chromosome, allele frequencies in cases and controls, the minor allele, odds ratios with 95% confidence intervals and allelic P-values for each study population. 
The effective size of the German population was 1,248 LLI and 6,762 younger controls; for the French 1,270 LLI and 1,824 younger controls, and for the Danish 1,002 LLI and 737 younger controls. 
aMinor allele frequency, MAF; the definition of the minor allele (MA) is based on controls 
bOdds ratio for longevity, OR; based on the MA in controls 
c95% confidence interval, 95% C.I.; C.I. for the OR 
dAllelic P-values, calculated with chi-squared test with one degree of freedom; Pcorr, corrected P-value using false discovery rate (corrected for three tests in the French and Danish study populations 
and for 62,488 tests in the German sample) 
eRandom-effects meta-analysis P value; fRandom-effects OR estimate; gP-value for Cochrane's Q statistic, Q; hI2 heterogeneity index (0-100) 
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Table 3.3. Association statistics for the 16 longevity-associated genes identified by the gene-based association approach in the whole German study population. 
    SNVs 
Gene Chr P_skato P_burden All Tested Rare Common No. rs 
APOE 19 3,25E-15 3,25E-15 2 2 1 1 rs769449, rs769452 
APOC1 19 2,59E-11 1,77E-02 3 3 0 3 rs439401, rs445925, rs4420638 
TOMM40 19 1,35E-06 4,34E-02 3 3 1 2 rs157580, rs2075650, rs142412517 
PGP 16 2,50E-06 8,90E-07 3 3 2 1 rs200526199, rs116977380, rs200615324 
OTOL1 3 2,56E-04 7,11E-06 5 5 3 2 rs199791179, rs149127996, rs199985412, rs3921595, rs202021352 
FN3KRP 17 9,19E-06 3,75E-02 5 5 3 2 rs138953335, rs61743692, rs144986629, rs142718764, rs1046896 
SETD9 5 1,19E-05 6,95E-05 6 6 4 2 rs2257505, rs149334074, rs40497, rs141692637, rs150526244, 
rs146260337 
RPS6KB1 17 1,56E-05 1,56E-05 2 2 1 1 rs201316437, rs1051424 
GRN 17 1,59E-05 8,28E-03 4 4 4 0 rs63750723, rs63750043, rs63750541, rs63750412 
PSG7 19 2,64E-05 4,19E-04 2 2 2 0 rs199532805, rs112354282 
SKOR1 15 3,38E-05 9,20E-05 2 2 2 0 rs200956599, rs143419968 
HNF4G 8 3,95E-05 2,17E-02 4 4 3 1 rs2943549, rs201625743, rs138897994, rs148532560 
ASB17 1 4,42E-05 4,22E-05 3 3 1 2 rs149522654, rs11161887, rs3795251 
SPZ1 5 8,09E-05 2,26E-04 5 5 2 3 rs1862136, rs139471643, rs184214819, rs200249535, rs35337118 
BFSP1 20 1,25E-03 6,00E-05 6 6 5 1 rs145703098, rs140116733, rs6080719, rs147718368, rs143865632, 
rs142092768 
HMHA1 19 1,54E-03 3,49E-05 8 8 5 3 rs1801284, rs2074442, rs36084354, rs142614852, rs150294461, 
rs139988914, rs61734935, rs139251906 
 
APOE, apolipoprotein E; APOC1, apolipoprotein C1; ASB17, ankyrin repeat and SOCS box containing 17; BFSP1, beaded filament structural protein 1; FN3KRP, fructosamine 3 kinase related 
protein; GRN, granulin; HMHA1, Rho GTPase activating protein 45; HNF4G, hepatocyte nuclear factor 4 gamma; OTOL1, otolin 1; PGP, phosphoglycolate phosphatase; PSG7, pregnancy specific 
beta-1-glycoprotein 7; RPS6KB1, ribosomal protein S6 kinase B1; SETD9, SET domain containing 9; SKOR1, SKI family transcriptional corepressor 1; SPZ1, spermatogenic leucine 
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Figure legends 
Figure 3.1. Workflow of the association analyses in the case-control study of longevity using the Illumina 
HumanExome BeadChip. 
 
Figure 3.2. Manhattan plot summarizing the findings from the single-variant analysis. The inner plot represents 
the basic association results, the outer plot the association results after conditioning for the longevity-associated 
locus TOMM40/APOE/APOC1. The y-axis shows the -log(P-value), while the red line depicts the P-value 
threshold (1 x 10E0-4). The SNVs with P < 1 x 10E0-4 are highlighted as red dots. 
 
Figure 3.3. Functional annotation map generated by ClueGo. The nodes represent the GO terms. The size of the 
nodes indicate the enrichment significance of the respective term (big node = high significance). 
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Figure 3.1 
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Figure 3.2 
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Figure 3.3. 
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4.1. Introduction 
Humans experience several changes during the aging process, some of them obvious, but others 
subtle, but still correlated with health maintenance or disease development, like changes in the 
gut microbiome (GM) composition. GM is a complex collection of microorganisms inhabiting 
our gastrointestinal tract. Immediately after birth, the gut is colonized, first by facultative 
anaerobes, followed by several successive remodelling steps which end in the colonization with 
strict anaerobes [1]. After the first settlement, the biodiversity of the GM increases and reaches 
a stable ecology structure at around an age of three years old [2]. In adulthood, the GM remains 
relatively stable and fecal bacteria in healthy adults are dominated by the phyla Firmicutes 
(families Lachnospiraceae and Ruminococcaceae), Bacteroidetes (families Bacteroidaceae, 
Prevotellaceae, and Rikenellaceae), and Actinobacteria (families Bifidobacteriaceae and 
Coriobacteriaceae) [2–5]. 
 
As soon as the GM has reached its biodiversity peak, the composition remains relatively stable 
for long periods of time [6]. However, GM appears to be very sensitive to changes in dietary 
patterns [5, 7], drugs or medical treatment [8, 9]. Furthermore, human genetics, ethnicity, and 
physiological shifts which occur during aging were shown to be relevant factors that shape the 
structure of the GM [10–13]. Interestingly, when humans reach extreme ages (older than 90 
years of age), certain patterns of the taxonomical composition of the GM apparently change, 
which results in a longevity-specific GM profile [14–16]. 
 
Despite extensive efforts to understand GM structure and composition, it remains unclear to 
which degree GM changes are attributed to ethnicity, diet, genetics, gender, and aging, 
respectively. For Germans, no systematic large-scale study on GM changes during aging in 
individuals covering a broad age range, including long-lived individuals (LLI, >90 years of 
age), has been conducted so far. In this study, we performed a human stool metagenomic 
analysis based on 16S rRNA in 1,301 healthy individuals of German ancestry (age range 19 to 
104 years) to i) identify age-related changes in the microbiome composition, ii) determine to 
which extent host genetics (associated with gut microbial composition and metabolic 
conditions) as well as environmental factors affect the gut microbial composition during aging, 
and iii) investigate whether there are any specific microbial patterns that characterize German 
LLI. 
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4.2. Results 
To investigate the characteristics of the gut microbiome in Germans during aging, we 
performed a large-scale 16S rRNA-based microbiome study in 1,301 healthy German 
individuals which covered the broad age range of 19 to 104 years of age. The individuals 
derived from three different sample collections, abbreviated as BSP/SPC, FOC, and AGE, 
respectively, with the latter cohort comprising the oldest (90+ years) participants. The 
characteristics of the different study populations are shown in Figure 4.1 and Supplementary 
table 1. 
 
4.2.1. Physiological parameters remain relatively stable during aging in healthy 
individuals 
Because the symbiotic microorganisms in the gut are susceptible to both external and host 
physiological factors, we first explored how selected physiological parameters of the study 
individuals change during aging and if anthropometric and dietary parameters contribute to 
explaining the morphophysiological changes. We first analyzed medical records of the study 
participants. Parameters with values for at least 70% of the individuals (n(parameters)=47; 
Supplementary table 3) were selected for the analysis. Principal component analysis (PCA) 
showed that both gender (Figure 4.2 A) and age groups (groups covering 30 years each) led to 
anthropometric profiles (Figure 4.2 B, C). Stratification by age was mainly explained by 
anthropometric parameters, while the inter-individual variability was largely due to dietary 
habits (Figure 4.2 B, C). To identify which of the anthropometric parameters correlated with 
age, we used a linear regression model independently for each gender. The model revealed a 
subtle difference between males and females. Along the age spectrum, both males and females 
significantly (P < 0.05) increased their waist-to-hip ratio (WHR), fiber consumption and the 
total energy intake. On the contrary, we observed a reduction of plant protein and long chain 
fatty acid intake as well as water consumption (Figure 4.2 C - E). In addition, in females, blood 
glucose concentrations tended to increase along the age spectrum. 
 
4.2.2. Four enterotype-like clusters stratify the GM and the global microbial diversity 
tends to increase with age, but appears to be lower in LLI 
To investigate potential alterations in the gut bacterial ecology caused by aging, we analyzed 
16S rRNA sequencing libraries of all 1,301 individuals. The assembly and binning of 
50,924,857 sequencing reads led to the identification of 1,255 OTUs (Supplementary table 
3). Subsequent taxonomical annotation revealed that more than 87.9% ± 15.8% of all bacteria 
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belonged to the three phyla Bacteroidetes, Firmicutes, and Proteobacteria, respectively, with 
the latter one representing the least abundant (in our samples 9.9% ± 11.6% of the total bacterial 
load; Figure 4.3). The Shannon index as a measure of alpha-diversity (i.e. the taxonomical 
composition) was not significantly different between the study cohorts (5.1 ± 0.37 for 
BSP/SPC, 4.92 ± 0.39 for FOC, and 4.7 ± 0.77 for AGE). 
 
To explore the gut microbiome stratification, we used a de novo enterotype identification 
approach. We identified four clusters (Figure 4.4 A, B); three were consistent with the already 
known Prevotella (ET_P), Bacteroides (ET_B) and Firmicutes (ET_F) enterotype, and the 
newly discovered fourth enterotype-like structure was driven by Escherichia shigella (ET_Esh) 
(Figure 4.4 A). When we compared the results of our enterotype prediction approach with the 
enterotypes generated with the enterotype classifier (http://enterotypes.org); 62.53% of our 
predicted enterotypes were concordant with the classifier output, 10% were swap-classified 
(ET_B as ET_F and vice versa) and 13.8 % represented a miss-classified enterotype (ET_Esh; 
ET_Esh was supposed to be classified as unknown (XO) as this enterotype is not recognized 
by the enterotype classifier; but instead was classified as either ET_B or ET_F) (Figure 4.4 C). 
We also observed that the proportion of the enterotypes differed between the three cohorts, but 
was not affected by age (Figure 4.4 D). The microbial diversity within the enterotypes was not 
statistically different either between males and females or between the cohorts (Figure 4.4 E); 
however, for all enterotypes, the GM tended to increase with aging. Strikingly, the diversity 
tended to decline in nonagenarians/centenarians, independently of the enterotype, and the lower 
diversity reached statistical significance for ET_Esh (Figure 4.4 E). 
 
4.2.3. Enterotypes explain 19.8% of the bacterial structure variability  
We further investigated changes in the beta-diversity (i.e. the comparison of the taxonomical 
composition between populations) in relation to the microbiome stratification, individual 
genetics, morphometric (Supplementary table 4) and dietary parameters by redundancy 
analysis (RDA; with P < 0.001). The results showed that enterotype, gender, age, WHR, BMI, 
intestinal inflammatory status (estimated from fecal calprotectin measurements), triglycerids in 
blood, dietary parameters (such as protein consumption, fibre, plant protein, alcohol intake), 
and the genetic variants rs958798-T (SNV annotated to KCNC4) and rs6666120-G (SNV 
annotated to ACTL8 ) explained 20.65% of the variability in bacterial abundance (Figure 4.5). 
Impressively, only the enterotypes accounted already for 19.8% of the variability (Figure 4.5 
B). When we considered the bacterial community structure of each enterotype separately, 
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anthropometric parameters, genetics, diet and blood values explained 4.9 % of the total 
variability (Table 4.1). Strikingly, age alone explained not more than 1.33% of the total GM 
variability (Table 4.1). 
 
Next, we tested if there were any differences in the bacterial diversity between the enterotypes. 
Using a zero-inflated Log-normal mixture modeling [17], we observed 32 differentially 
abundant genera between the enterotypes (P < 0.05) (Supplementary table 5). We investigated 
the functional implications of the 32 genera with Tax4Fun [18] and, subsequently, determined 
the distinctive metabolic components using MetaPath thresholds [19]. This approach yielded 
624 significant reactions (P <0.01) and 69 sub-pathways (P < 0.05), which were differentially 
abundant between the four enterotypes (Supplementary figure 1, Supplementary table 5, 6). 
The enriched pathways comprised: for ET_P, those related to folate biosynthesis, vitamin 
B6/B3 metabolism, beta-Alanine metabolism, lipopolysacharides biosynthesis; in ET_B, 
butanoate, synthesis and degradation of ketone bodies, vitamin B3 metabolism; in ET_F, 
pathways related to biosynthesis of ansamycins, thiamine metabolism, porphyrin and 
chlorophyll metabolism, and in ET_Sh, pathways related to tyrosine metabolism. 
 
4.2.4. Microbial changes associated with aging 
One major goal of our study was to identify microbial changes that occur during aging. We 
used the software MaAslin2 [20] to model the effects of age on microbial occurrences and 
included the anthropometric, genetic, and dietary parameters as covariates. The abundance of 
43 genera correlated significantly with age (Figure 4.6, Supplementary table 7). Positive 
correlations were seen for bacterial communities such as Desulfovibrio, Oxalobacter, some 
butyrate-producing bacteria (Roseburia, Butyrivibrio, and Anaerotruncus), and families that 
may influence host metabolism, in particular Coriobacteriaceae Erysipelotrichaceae, and 
Victivallaceae. Interestingly, the families Enterobacteraceae and Peptostreptococcaceae and 
the class Gammaproteobacteria, which were negatively correlated with age in our analyses, 
were previously shown to be associated with health conditions like colorectal cancer, diarrhea, 
and Crohn´s disease [21] [22]. Noteworthy, with increasing age, we observed a significant 
increase in the occurrence of unknown bacteria (P = 8.97E-03, Padj. = 0.097, Figure 4.6). 
 
We payed special attention to differences in the microbial abundance in healthy LLI (>90 years 
of age) compared with younger study participants. MaAslin2 identified 45 genera with 
differential occurrence between LLI and either elderly (75 - 80 years old) or younger adults 
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(<75 years old) (Figure 4.7, Supplementary table 8). In the LLI, we observed a higher 
abundance of so-called "pathobionts" such as Clostridiales, Enterococcus, Enterobacteraceae, 
Klebsiella, Lactobacillus, Prevotella, Pseudomonas and Streptococcus. In contrast, beneficial 
butyrate producers such as Eubacterium, Faecalibacterium, Roseburia and Coprococcus 
showed a lower abundance in the LLI. Furthermore, the LLI exhibited elevated levels of 
Eggerthella, Bifidobacterium, Anaerotruncus, Eggerthella, fusobacterium, and Pseudomonas 
(Figure 4.7). 
 
4.3. Discussion 
We investigated the role of aging on the microbial composition in healthy individuals from 19 
to 104 years old. We identified moderate but significant changes that occur during aging, and a 
specific pattern in nonagenarians and centenarians. Interestingly, the BSP/SPC and FOC 
cohorts exhibited different enterotype proportions (Figure 4.4 D). The correction for 
enterotypes reduced the confounding bias and increased the comparability of findings from the 
different cohorts. 
 
Fecal bacteria in healthy adults are dominated by the phyla Firmicutes (families 
Lachnospiraceae, Ruminococcaceae, and Veillonellaceae), Bacteroidetes (families 
Bacteroidaceae, Prevotellaceae, Porphyromonadaceae, and Rikenellaceae), and 
Actinobacteria (families Bifidobacteriaceae and Coriobacteriaceae) [2–5]. As expected, our 
results were in line with this pattern, apart from the third dominant phylum which, in our case, 
was Proteobacteria (family Enterobacteraceae) (Figure 4.4). For the latter phylum, we 
observed a continuous increase in the abundance of the genera Desulfovibrio, Oxalobacter, 
Klebsiella, and Hafnia with aging. This was independent of both the enterotype class and 
anthropometric parameters of the individuals. Both Klebsiella and Hafnia were shown to be 
able to secrete small molecules known as siderophores, which enable bacteria to compete with 
the host for iron [23, 24]. This competition can disturb the iron pool of the mucosal cells, which 
may in turn provoke the activation of innate and adaptive immune responses including 
proliferation, differentiation and secretion of inflammatory cells and mediators, respectively 
[25, 26]. In mice, members of the phylum Proteobacteria, such as Desulfovibrio, have been 
previously suggested to contribute to the chronic low-grade inflammatory state observed with 
advanced age [27]. Therefore, it is tempting to speculate that Desulfovibrio, Klebsiella and 
Hafnia are active players of the human GM that contribute to the pro-inflammatory status of 
elderly people. 
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Both the gastrointestinal tract as well as dietary habits of humans are known to undergo 
substantial changes with aging, which lead to a gradual shifting of the GM over time [28–30]. 
In our study, dietary patterns substantially explained the inter-individual variation observed 
along the age spectrum and between males and females (Figure 4.2): Examining the taxa profile 
more closely, we identified Parabacteroides (family Porphyromonadaceae), Alistipes (family 
Rinkenellaceae), and Dialister (family Veillonellaceae) as the most abundant genera (Figure 
4.4). These taxa have been previously associated with normal GM in adulthood and they may 
be preventive for obesity [31–33]. Dialister has been related to diets rich in fiber and whole 
grains, and to improvements in physiological measures of the host like reduced plasma 
interleukin-6 (IL-6) and reduced postprandial glucose levels [34]. Therefore, Parabacteroides, 
Alistipes and Dialister may exert health-promoting effects during aging, especially conferring 
resistance to low-grade inflammation (the so-called "inflammaging") [35]. Therapeutic 
measures to increase these beneficial bacteria in the GM could facilitate healthy aging. 
 
Strikingly, the enterotype-like clusters explained most of the inter-individual variation (19.8 
%). It has been suggested previously that enterotypes differ in terms of functional and 
ecological properties. For example, ET_P or Prevotella was shown to be enriched in individuals 
with non-Western and/or fibre-rich diets [36, 37]. Prevotella possess particular hydrolases 
specialized in plant-fiber degradation and a reduced lipolytic and proteolytic fermentation 
potential [38, 39]. In contrast, ET_B was reported to be associated with diets rich in animal 
protein and saturated fats and, additionally, Bacteroidetes were shown to exhibit an increased 
carbohydrate metabolism [38–41]. Accordingly, our functional predictions on the basis of the 
identified enterotypes supported the lipolytic, proteolytic and saccharolytic metabolism of 
ET_B (Supplementary figure 1, Supplementary table 5). For ET_P, we predicted an 
increment in fatty acid, folate, cofactor and vitamin biosynthesis, as reported previously [42]. 
Apart from ET_B and ET_P, we observed an Enterobacteraceae enterotype, (ET_Esch) with 
Escherichia-Shigella as its main driver. Despite members of the family Enterobacteraceae, 
including E. coli, Klebsiella spp and Proteus spp, were recognized to preferentially settle in 
inflamed environments [43–45], the Enterobacteraceae enterotype has not been associated as 
a cause of a pro-inflammatory status so far [46, 47]. Moreover, our results did not show any 
correlation of ET_Esch either with any of the available pro-inflammatory markers or with age 
or gender. Furthermore, despite our functional predictions of ET_Esch showed enrichment in 
pro-inflammatory pathways (Supplementary figure 1, Supplementary table 5), we did not 
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observe any evidence for a correlation of ET_Esch with a pro-inflammatory status or age-
related diseases or dysbiosis. 
 
From a taxonomical point of view, ET_Esch was enriched in Acinetobacter, Hungatella, 
Coprobacillus, Enterococcus, Klebsiella, Enterobacteriaceae and Escherichia-Shigella. 
Interestingly, we found Acinetobacter to be positively correlated with BMI and Hungatella with 
female gender. Furthermore, abundance of Escherichia-Shigella was inversely correlated with 
water intake and the G-allele of rs4973961 (in the gene Unc-51 Like Kinase 4 (ULK4)) 
(Suppelentary figure 2, Suppelentary table 7). Rs4973961-G has already been associated 
with microbial taxonomies and functional units previously [12]; specifically, a negative 
correlation with both thiamine biosynthesis and presence of Bifidobacteriales (some of its 
members are opportunistic pathogens [48]) has been reported [12]. Here, we observed 
rs4973961-G to be negatively correlated with opportunistic pathogens such as Haemophilus, 
Veillonella and Escherichia-Shigella, but to be positively correlated with Christensenella. The 
latter taxon has been linked to health-promoting effects and was shown to be strongly 
influenced by the genetic makeup of the host [49]. Therefore, our results might indicate a pro-
inflammatory microbial signature in the gut of the study participants carrying this ET, although, 
in our healthy individuals, this was not yet reflected in the values of the collected inflammatory 
markers like calcprotectin. However, in a diseased state, ET_Esch could influence disease 
progression [43–45]. Furthermore, with the association between ET_Esch and rs4973961, we 
showed that the likelihood of carrying ET_Esch could be determined by host genetic factors. 
 
Aging entails significant changes in body constitution. These changes include quantitative and 
qualitative progressive loss of skeletal muscle mass together with a body fat redistribution and 
an increase in low-density lipoprotein levels (LDL), triglycerides and pro-inflammatory 
cytokines (i.e. IL-6), independent of any disease development [50–52]. In the individuals 
included in this study, which were all healthy Germans, BMI, WHR, GGT, HDL, triglycerides, 
calprotectin, creatinine and blood glucose levels correlated with aging (Figure 4.2). 
Additionally, BMI, WHR, triglycerides, calprotectin, and glucose in blood explained changes 
in some specific taxa during aging (Suppelentary figure 2, Suppelentary table 7). However, 
the GM profile of the healthy agers in our study showed a tendency towards a higher diversity 
and several taxa with health-promoting effects such as butyrate-producers and regulators of 
metabolic processes (Figure 4.6). With advancing age, we observed a continuous increase in 
butyrate-producing bacteria (Roseburia, Butyrivibrio, and Anaerotruncus); furthermore, in 
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Oxilobacter, which potentially contribute to protection from calcium oxalate kidney stones [53, 
54], the family Coriobacteriaceae, which plays an important role in fatty liver disease and 
obesity [55], and Erysipelotrichaceae, which were shown to be positively associated with 
changes in liver fat content in humans and host lipid metabolism [56–58]. Moreover, we 
observed a reduction in Peptostreptoccoccus and Gamaproteobacteria, which have been 
associated with colorectal cancer and behavioral disorders, respectively [59]. Interestingly, we 
observed that during aging, the abundance of Bacteroidales S24-7 tended to increase, in contrast 
to a decrease in Coprobacter. Such a pattern has been previously observed in Chinese 
individuals on a high-fat diet [60]; therefore, these bacteria might contribute to the increase in 
BMI and triglycerides observed in our individuals during aging. 
 
Physiological shifts in the gut environment (e.g. higher levels of pro-inflammatory cytokines, 
thinning of the mucosal layer in the gut) during aging allow the colonization of opportunistic 
pathogens [28–30]. In the present study, we identified Cloacibacillus, which has been 
previously reported to be associated with intestinal infections [61]. Furthermore, we found 
Holdemanella, previously shown to be associated with an unhealthy serum lipid profile (low 
HDL cholesterol and/or high triglycerides or high LDL cholesterol) in obese women [62] as 
well as Fusobacterium, Blautia and Enterobacteraceae, which are all typical inhabitants of pro-
inflammatory environments [26, 63]. 
 
It has been previously stated that in LLI, the GM exhibits an adaptive remodeling; in an extent 
that would even justify to consider centenarians as a separate population [14, 15, 64]. Our 
results are in line with this hypothesis and substantiate in large part the microbial profile seen 
in nonagenarians/centenarians from Japan [16], China [65], and Italy [66, 67]. However, we 
observed a few differences from earlier reports, i.e. German LLI exhibited a higher abundance 
of Ordobacter and Parabacteroides, which resembles Chinese centenarians [65]. Furthermore, 
German LLI also displayed depletion in Lachnospiraceae and Akkermansia, which has been 
previously observed in Japanese nonagenarians/centenarians [16]. Some other differences that 
we observed are likely explained by the differences in the dietary patterns between populations 
of different cultures. For example, we noticed an elevated abundance of Halomonas, 
Lactobacillus and Shewanella, which alltogether have been associated with ingestion of 
fermented foods [68]. We also detected an overall reduced bacterial diversity in the LLI 
compared with younger study participants (Figure 4.7) and, specifically, a reduced abundance 
of Coriobacteriaceae, Eubacterium and Oxalobacter, while Lachnoclostridium abundance was 
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increased. This pattern partially resembles the signature of antibiotic treatment [8]. Although 
we excluded individuals who had reported antibiotic treatment, we cannot rule out 
misreporting. Moreover, in the LLI, we found an elevated abundance of Eggerthella, which has 
been linked to cardiac medication [9]. 
 
4.4. Material and methods 
Study populations 
The study included participants from three different sample collections from Schleswig-
Holstein (Germany), abbreviated as BSP/SPC, FOC, and AGE. The BSP/SPC cohort comprised 
601 individuals, 1,115 individuals derived from the FOC cohort, and 22 individuals were 
recruited for the AGE cohort (Supplementary table 1). The study cohorts were recruited 
independently from each other with the help of the biobank Popgen [69]. Popgen also provided 
the corresponding phenotype and genotype information [69]. Fecal samples were collected by 
the participants at home using standard fecal tubes. Samples were kept at room temperature and 
either shipped or brought to the collection center by the participants themselves (within 24 
hours after collection). Samples were stored at −80 °C until further analysis. All study 
participants provided a signed written informed consent prior to enrollment in the study. 
Approval for the study was obtained from the Ethics Committee of the Medical Faculty of Kiel 
University. 
 
Genotyping data 
Samples of the BSP/SPC and FOC cohorts were genotyped on different genotyping arrays. 
BSP/SPC samples were genotyped using the following chips: Affymetrix 6.0, Affymetrix 
Axiom, Illumina 550k, custom Illumina Immunochip and Illumina Metabochip arrays, with 
sample sizes ranging from 678 to 1,218 before quality control and variant coverage of 196,524 
to 934,968 variants. The FOC samples were genotyped on the custom Illumina Immunochip 
(Illumina Inc., San Diego, USA) and the Omni Express Exome (Illumina Inc., San Diego, 
USA), with 1,024 and 1,713 samples before quality control, respectively, and a variant coverage 
of 195,732 to 964,193 variants. For each cohort, genotype data from every array underwent 
quality control separately and, subsequently, data were merged and imputed. For our study, we 
included 325 single-nucleotide variants which had been previously reported to be associated 
with the gut microbiome [11, 12, 49, 70, 71] and 11 SNVs associated with longevity (annotated 
to the genes FOXO3 [72] and APOE [73], respectively) (Supplementary table 2). 
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DNA extraction and 16S rRNA sequencing 
Bacterial genomic DNA was extracted using the QIAamp DNA Stool Mini kit from Qiagen on 
a QIAcube system (Promega Corporation, Madison, USA). The V1–V2 region of the 16S rRNA 
gene was sequenced on the MiSeq platform using the 27F–338R primer pair and dual MID 
indexing (8 nt each on the forward and reverse primers) as described previously [74]. 
Sequencing was performed with the MiSeq Reagent Kit v2. After sequencing, MiSeq fastq files 
were obtained from base calls for paired-end reads and both indices (I1 and I2) using the 
Bcl2fastq module in CASAVA 1.8.2 (Illumina Inc., San Diego, USA). Stringent de-
multiplexing was carried out by allowing no mismatches in none of the index sequences. 
 
Processing of sequencing dataset 
Paired-end reads were processed with Mothur v 1.36.5 [75]. To minimize effects of sequencing 
errors, sequences that contained more than one undetermined nucleotide, had more than six 
homopolymers, or showed a Q-score average < 25 in a window of 50 pb were trimmed. 
Trimmed sequences with a length <250 pb were eliminated. Spurious sequences were reduced 
in two steps. First, a pre-clustering step for noise reduction was performed as described 
previously [76], and second, a chimeras’ elimination using Vsearch algorithm [77]. High-
quality trimmed reads were used to calculate an uncorrected distance matrix. This matrix was 
used to cluster the sequences into OTUs of 97% similarity with the opticlust algorithm [78]. 
Taxonomical annotation of the OTUs was done using the consensus taxonomy of the sequences, 
which were identified with the Bayesian-RDP classifier [79] and the SILVA reference database 
release 123 [80]. Prior to statistical analysis, the OTU-count table was pre-processed to reduce 
spurious and chimeric OTUs which met the core measurable microbiome threshold (CMMt) 
[81] CMMt was calculated according to pairwise combinations of technical replicates of 49 
different samples. For each sample, CMMt was defined as the minimum number of reads for 
which correlation between technical replicates was higher than 80%. Therefore, only OTUs 
were retained, whose count values were above the average CMMt and which were present in at 
least 2% (size of the smallest cohort (LLI)) of the libraries. 
 
Statistical analysis  
Morphophysiology across samples was explored by multiple factor analysis. Missing values 
where imputed using a multivariate approach [82]. OTU counts were normalized by the total-
sum scaling method [17]. The R packages vegan [83] and metagenomeSeq [17] were used to 
calculate the alpha- and beta-diversity on the basis of the normalized counts. Principal 
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Coordinate Analysis (PCoA) based on Bray-Curtis dissimilarity [83] was used to assess 
differences in the community composition across samples. Enterotype-like microbiomes were 
identified using a de novo clustering and reference classification approach. Clusters were 
generated using partition around medoids over a Jensen-Shannon dissimilarity matrix. The 
number of optimal clusters was calculated with the silhouette and gap statistic method with a 
500 times Monte Carlo re-sampling [84]. Additionally, the enterotypes were imputed using the 
enterotype classifier (http://enterotypes.org), which is limited to the identification of three 
enterotypes [7]. Differentially abundant genera between enterotypes were identified employing 
the Log-Normal zero-inflated mixture model [17]. Differentially abundant taxa during aging 
were analyzed using the multivariate statistical framework MaAsLin2 [20] which performs 
boosted, additive, general linear models between metadata and microbial abundance data. 
 
Functional prediction 
Prediction of functional profiles was performed on the basis of SILVA-labeled OTU 
abundances using Tax4Fun [18]. Differentially abundant pathways and reactions were 
identified by MetaPath [19]. Enriched pathways were determined based on two P-values, 
pabund and pstruct [19], and enriched reactions were selected based on pabund only. 
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Tables 
Table 4.1. Environmental factors that significantly contribute to shaping of the microbial structure of the study population. 
Environmental 
factor Explanatory variable 
Explained variability 
ET_Ech  ET_P  ET_F  ET_B 
By variable (%) Total (%)  By variable (%) Total (%)  By variable (%) Total (%)  By variable (%) Total (%) 
Anthropometrics 
Age 0.92 
4.58 
 0.32 
 
 
 
 
 
 
 
 
4.9 
 1.33 
2.7 
 0.41 
3.9 
WHR 1.61  2.1  0.24  1.44 
BMI 0.85       
Blood 
measurements 
Triglycerides     0.33  0.48 
Glucose       0.11 
Calprotectin   0.83     
Dietary 
Alcohol 0.52  1.1    0.31 
Long-Chain faty acids       0.16 
Fibre       0.98 
Total energy   0.55     
Genetic 
HIVEP3_rs12563071_T 0.68       
ACTL8_rs6666120_G     0.54   
KCNC4_rs958798_T     0.21   
 
BMI, Body Mass Index; ET, enterotype [Ech, Escherichia shigella; P, Prevotella; F, Firmicutes; B, Bacteroides]; WHR, Waist-to-hip ratio 
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Figure legends  
Figure 4.1. Age distribution of the individuals enrolled in the study. The age distribution is 
shown separately for males and females. 
Figure 4.2. Relationships among anthropometric measures, dietary parameters and the 
age of the individuals. A - B. Principal component analysis showing how dietary and 
anthropometric parameters shape the inter-individual variability of the 1,301 healthy 
individuals. C - E. Linear regression between anthropometric parameters and age. C. Prediction 
model was explained with determination coefficient of 0.395 for males and 0.306 for females. 
Determination coefficient (R2) was adjusted for the number of prediction variables in the 
model. D. Residual plot of the prediction models. 
Figure 4.3. Gut bacterial diversity of healthy Germans across a broad age range. Relative 
abundances of the ten most abundant phyla, orders, families and genera for each age group. 
Figure 4.4. Microbial stratification and enterotype-specific alpha diversity. A. Principal 
coordinate analysis (PCoA) based on Jensen-Shannon dissimilarity matrix on the basis of the 
GM profiles of the subjects. B. Optimal number of clusters estimated by the gap statistic method 
with a 500 times Monte Carlo re-sampling. C. Enterotype de novo classification in comparison 
with the enterotypes obtained with the enterotype classifier (http://enterotypes.org). D. 
Enterotype distribution in relation to the age sets, population-cohorts and gender. E. GM 
diversity based on the Shannon diversity index in relation to the enterotypes, population-cohorts 
and gender. F. GM diversity based on the Shannon diversity index in relation to the enterotypes, 
population-cohorts and age sets. 
Figure 4.5. Inter-individual GM variability explained by microbial stratification, dietary 
and anthropometrics parameters. A. Redundancy analysis (RDA) biplot representing the 
relationship between the explanatory variables and the relative abundance of bacterial 
communities. The biplot map explains 15.9% of the total variability. B. Contribution plot for 
the explanatory variables; depicted variables explain 21.6% of the total variability. 
Figure 4.6. Taxa whose abundances change during aging. Forty-three genera whose 
occurrence is associated with age. 
Figure 4.7. Differentially abundant taxa in LLI compared with younger subjects. Twenty-
two genera with differential abundance between LLI and younger subjects. 
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 5.  
Conclusion and outlook 
“Aging seems to be the only available way to live a long life.” 
Daniel-Francois-Esprit Auber, French composer 1782-1871 
 
Every human being on earth faces aging and, so far, no one can escape the aging process. Only 
a few individuals achieve the very special phenotype "longevity". While LLI also do age and 
show clear signs of aging (wrinkles, grey hair, etc.), they seem to grow old in a more healthy 
manner than average-lived people. Disentangling the tight link between aging and longevity is 
difficult and has been occupying researchers all over the world for decades. The work presented 
in this thesis has clearly shown that we are still far from a comprehensive understanding of the 
highly complex mechanisms influencing (healthy) aging and longevity. Thus, only a broad view 
of these phenomena will eventually enable us to identify the underlying regulatory pathways. 
 
Figure 5.1 summarizes the aims, methods and results of the three chapters of the present work. 
Chapter I comprised basic research on aging and development in the relatively simple model 
organism Hydra. Fundamental aging mechanisms and involved genes overlap widely between 
different species like Hydra, Drosophila or mice and humans. Thus, research in animals can 
help overcome experimental and ethical limitations that are often encountered in studies 
involving humans. Chapter III (gut microbiome in aging) once more highlights the complexity 
of aging that is exacerbated if we consider human genome–microbiome-environment 
interactions. Another challenge in aging studies is to unravel causes of aging from its 
consequences. This challenge was met in chapter II (genetics of human longevity), where the 
identified SNVs are constitutive and must therefore underlie the longevity phenotype instead 
of being a consequence of it. 
 
Each chapter is a stand-alone project; at different levels, however, they all revolved around the 
central topic of how to influence or manipulate the aging process to achieve healthy longevity. 
Every chapter also revealed either limitations of the respective study design or results that 
cannot be explained with our current level of understanding. 
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Figure 5.1. Overview of the three research projects and their respective outcomes. 
 
CI, control individuals; COG, cluster of orthologous groups; GM, gut microbiome; HDAC, 
histone deacetylase; KEGG, Kyoto Encyclopedia of Genes and Genomes; LLI, long-lived 
individuals; SNV, single nucleotide variant. 
 
Intriguingly, in the three chapters, FOXO has not shown up as a common denominator. The 
important role of this gene in longevity and lifespan regulation is undisputed. Not surprisingly, 
FOXO was recently suggested as a "critical rate-of-aging-regulator" [1].  
In Hydra, FoxO drives developmental processes and stem cell renewal [1]. In the Hydra 
subproject (chapter I) FoxO expression was detected in all the in situ GFP-experiments and also 
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the differential FoxO expression between body and head was observed. However, for unknown 
reasons, this differential FoxO expression was not confirmed either in the microarray or the 
RNA sequencing data. Furthermore, the epigenetic modifications in terms of DNA de-
acetylation apparently left FoxO expression patterns unaffected; at least, they did not change to 
a measurable extent. These results were completely unexpected. It could well be that FoxO 
expression in Hydra is restricted to one specific tissue layer (most likely the epidermal layer 
(ectoderm)) and that by performing a transversal cut through the Hydra tissue during the 
experiment, the expression was diluted to a level below the detection limit. Single-cell 
transcriptomics or layer-specific analyses could help to answer this question in the future. 
FoxO was recently shown to fundamentally affect both the microbiome composition and 
resilience in Hydra [2]. Drosophila exhibited an age-related increase in FoxO activity, which 
correlated with a higher bacterial load [3]. Congruently, Drosophila with impaired FoxO 
signaling were found to be more prone to intestinal infections [4]. In the nematode C. elegans, 
longevity was linked to Bacillus subtilis biofilm formation, driven by Daf16, the worm 
orthologue of human FOXO3 [5, 6]. Furthermore, the pro-longevity effect of metformin, a 
potent FOXO3-inducing drug [7], is known to be indirectly mediated by its influence on 
bacteria, particularly via inhibiting bacterial folate and methionine metabolism [8]. Taking 
these observations into account, it is surprising that in the microbiome subproject (chapter III) 
no influence of FOXO3 variants on the intestinal microbiome was detected. Studies in model 
organisms are generally highly standardized in terms of environment, genetic background, and 
diet, while in humans a potential influence of FOXO3 variants on the microbiome – if present 
– was likely masked by other factors (e.g. diet, genetic background, etc.).  
 
FOXO3 variants were consistently reported to be associated with human longevity. In chapter 
II, no FOXO3 variants were significantly associated with longevity. However, this was 
anticipated as coding variants in FOXO3 had previously been shown to be unlikely key 
determinants - the FOXO3-longevity-association rather seems to be driven by intronic SNVs 
[9]. Therefore, exonic FOXO3 variants covered by the exome chip were a priori not expected 
to yield statistically significant longevity associations. 
 
It is intriguing that despite extensive research efforts, all currently known longevity variants 
together explain not more than approximately 1 or 2% of the estimated total heritability [10]. 
This may point towards an analytical bias that has left many genetic factors contributing to 
human longevity undiscovered so far, in agreement with the research hypothesis of chapter II. 
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However, another possibility is that the longevity heritability is highly overestimated, as 
claimed in a recent paper [10]. The latter option is currently the subject of controversial 
discussion in the longevity community. The work on chapter II also revealed limitations of the 
commonly applied approaches. The analysis of joint effects of rare and common variants within 
one genetic region added substantial value to the initially performed traditional single-variant 
association analysis. This highlights the importance of being open to new methods and/or 
combinations of existing ones as they can help to discover new or validate previous findings. 
Besides, it might be time to rethink longevity association studies - hypothesis-free GWAS prove 
successful in discovering genetic variants with huge effect sizes or associated with highly 
prevalent diseases/phenotypes, but they are obviously unrewarding in longevity research. 
Hypothesis-driven, potentially evolutionary-informed, approaches may be more promising. 
Furthermore, up to date, there is no consensus about an/the ideal design for longevity studies in 
humans, if there is any at all. As a result, published studies are often hard, if not impossible, to 
compare. Longevity is such a rare phenotype that the recruitment of LLI, especially 
centenarians, semi-super-centenarians and super-centenarians is very challenging. The 
selection of proper control individuals is not less problematic when taking into account birth 
cohort effects [11, 12]; there are generally no controls available from the same birth cohort the 
LLI belong to. Cut-offs for cases and controls appear highly variable and sometimes even 
specific to one study. Both hard age cut-offs or age ranges (90+ yrs, 95+ yrs, 98+ yrs, 100+ yrs 
and 50-65 yrs, <65 yrs, <70 yrs, <85 yrs for cases and controls, respectively) and percentile 
thresholds (e.g. >90th/ 99th percentile and <60th percentile for cases and controls, respectively) 
are chosen apparently almost arbitrarily. In view of these challenges, studies with centenarian 
offspring and parental lifespan, respectively, appear promising. However, these studies come 
with the drawback of genotype and phenotype “dilution”. 
 
Environmental factors affect longevity to a much greater extent than genetics, probably even 
more than the currently estimated ~70-80%, if in fact the lower heritability of the phenotype 
proves to be correct. Noteworthy, in contrast to the unchangeable genetic architecture, 
environmental factors are generally modifiable.  
 
The gut microbiome is increasingly gaining attention in aging and longevity research. 
Maintaining a healthy gut microbial architecture appears to be of utmost importance for staying 
healthy while growing old. In chapter III, the microbial composition remained mostly stable in 
healthy individuals during aging, which supports previous findings [13]. Strikingly, age-related 
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diseases often coincide with dysbiosis [14, 15]. The results obtained in chapter III highlighted 
the relevance of environmental factors as determinants of the gut microbial composition. The 
thesis has shown that with only 1% in magnitude, the effects of host genetics on the microbial 
structure in the intestine were remarkably low, while all collected environmental factors 
combined contribute 5% when the microbial population stratification was removed. This is in 
concordance with results obtained by others [16]. The gut microbiota can be regarded as a major 
target of intervention strategies to maintain or restore a stable healthy gut flora. Indeed, first 
attempts to restore a healthy gut microbial structure, e.g. by treatment with pre- and probiotics 
or fecal transplantation yielded promising results [16]. Infants may deserve special attention as 
the importance of environmental factors might be greatest in this age group when the microbial 
architecture has not stabilized yet. Therefore, early factors (e.g. delivery, breast milk, animal or 
formula milk, hygiene) likely have long-term consequences. Noteworthy, the example of the 
metformin-treated C. elegans mentioned above supports the notion that the individual microbial 
metabolic potential can affect the therapeutic response to drugs. This might eventually enable 
us to develop personalized approaches to fight aging and age-related diseases and to achieve 
longevity.  
 
Generally, there is low consistency among microbiome studies. Some of the observed 
differences may be, at least partly, the result of cultural differences in lifestyle and diet. 
However, also methodological issues may contribute to discrepant observations, for instance, 
differences in the sampling procedure, DNA extraction protocol, or handling of sequencing 
errors, to name but a few. To avoid false conclusions, comparisons should ideally be restricted 
to within one study. Furthermore, in future aging-microbiome-studies, it might be advisable to 
stratify elderly participants according to their health status to avoid too much variation in the 
data. This approach would require bigger population sizes to retain statistical power. 
 
One challenge that remains is to distinguish between effects due to the aging process per se and 
those caused by changes in diet and lifestyle associated with aging. The thesis contributed to 
this with deep bioinformatic analyses; however, the complexity of the data and the fact that the 
study participants derived from three different sample collections, for which different (though 
overlapping) phenotypes were collected, made this work particularly challenging. Large-scale 
studies with comprehensive phenotyping and categorization of participants by health status 
might be one way to address the current challenges of microbiome research. To summarize, gut 
microbes are clearly associated with both health and disease and the environment impacts 
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considerably on both the gut microbial composition and the likelihood of becoming long-lived. 
With this in mind, the identification of the key environmental drivers of these two phenotypes, 
gut microbial architecture and longevity, should be a focus in future studies. 
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 6.  
Summary 
Human aging is characterized by progressive functional decline that coincides with both 
increased morbidity and mortality. Aging affects every human being and only few individuals 
achieve longevity, a very special phenotype marked by extraordinary healthy aging. This thesis 
consists of three chapters; each one is devoted to a separate project that contributes to the 
growing body of knowledge about aging and longevity. The work required the compilation, 
management and analysis of diverse big data sets and the application of cutting-edge statistical 
and computational methods. 
 
Chapter 1 - A functional genomics study was conducted in the potentially immortal freshwater 
polyp Hydra using body part-specific microarray and RNA sequencing data. The results 
revealed gene expression patterns that allow boundary maintenance during Hydra’s continuous 
cell proliferation and tissue self-renewal. Furthermore, this study provided evidence for de-
acetylation as a key mechanism underlying compartmentalization. Surprisingly, FoxO, which 
is known to substantially drive developmental processes and stem cell renewal in Hydra, did 
not seem to be affected by the acetylation status. 
 
Chapter 2 - Long-lived individuals (LLI, >95 years of age) epitomize the healthy aging 
phenotype and are thought to carry beneficial genetic variants that predispose to human 
longevity. Despite extensive research efforts, only few of these genetic factors in LLI have been 
identified so far. In contrast to previous investigations which mainly focused on intronic 
variants, a genome-wide exome-based case-control study was performed. DNA samples of 
more than 1,200 German LLI, including 599 centenarians (≥100 years), and about 6,900 
younger controls were used for single-variant and gene-based association analyses that yielded 
two new candidate longevity genes, fructosamine 3 kinase related protein (FN3KRP) and 
phosphoglycolate phosphatase (PGP). FN3KRP functions in the deglycation of proteins to 
restore their function, while PGP via controlling glycerol-3-phosphate levels affects both 
glucose and fat metabolism. Given the biological functions of the genes, their longevity-
associations appear very plausible. 
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Chapter 3 - In recent years, the intestinal microbiome (GM) has increasingly gained attention 
in aging and longevity research. A 16S rRNA microbiome study was conducted using 1301 
stool samples of healthy individuals (age range: 19 - 104 years) that were drawn from three 
cohorts. The aim was to investigate potential associations among GM composition, host 
genetics and environmental factors during aging. The GM composition changed with age, 
showing an increase of opportunistic pathogens that may generate an inflammatory 
environment in the gut. Age explained only ~1% of the inter-individual variation, whereas 
anthropometric measures, genetic background and dietary patterns together explained 20%. 
Strikingly, clear GM population stratification in terms of four enterotype-like clusters was 
observed, which were predominantly associated with dietary patterns. The correction for these 
clusters was shown to increase the comparability of findings from the different cohorts. In 
addition, the LLI showed a specific gut microbial pattern, which is in line with previously 
published reports. 
 
The present work shows that a thorough bioinformatics expertise helps to address the 
complexity of the two phenotypes aging and longevity. One highlight of the thesis is the 
discovery of two new candidate longevity loci that, in view of the limited output of previous 
study approaches, enlarge the existing database.  
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 7.  
Zusammenfassung 
 
Altern geht beim Menschen mit fortschreitender Funktionalitätsabnahme des Organismus und 
erhöhter Morbidität und Mortalität einher. Jeder Mensch altert, jedoch nur wenige Individuen 
erreichen Langlebigkeit - ein besonderer Phänotyp, der durch eine außergewöhnlich gesunde 
Form des Alterns gekennzeichnet ist. Die vorliegende Doktorarbeit besteht aus drei Kapiteln, 
die jeweils einem separaten Projekt gewidmet sind. Alle drei Projekte tragen zur Erweiterung 
des Kenntnisstandes zu Altern und Langlebigkeit des Menschen bei. Die geleistete 
Forschungsarbeit erforderte Zusammenstellung, Management und Analyse diverser großer 
Datensätze sowie den Einsatz modernster statistischer und bioinformatischer Methoden. 
 
Kapitel 1 - Am potenziell unsterblichen Süßwasserpolyp Hydra wurde eine funktionell-
genomische Studie unter Verwendung von körperbereich-spezifischen Microarray- und RNA-
Sequenzierungsdaten durchgeführt. Die Ergebnisse zeigten Genexpressionsmuster, die die 
Aufrechterhaltung abgegrenzter Körperbereiche während der kontinuierlichen Zellproliferation 
und Selbsterneuerung der Gewebe von Hydra ermöglichen. Darüber hinaus lieferte die Studie 
Belege, dass Deacetylierungsreaktionen eine Schlüsselfunktion bei der Kompartimentierung 
zukommt. Überraschenderweise schien FoxO, ein Gen, das bekanntermaßen 
Entwicklungsprozesse und Stammzellerneuerung in Hydra wesentlich vorantreibt, vom 
Acetylierungsstatus nicht betroffen zu sein. 
 
Kapitel 2 - Langlebige Individuen (engl. long-lived individuals, LLI; >95 Jahre) verkörpern 
den Phänotyp des gesunden Alterns. Es wird vermutet, dass sie genetische Varianten tragen, 
die für Langlebigkeit beim Menschen prädisponieren. Trotz umfangreicher Forschung konnten 
bisher nur wenige dieser genetischen Faktoren in LLI identifiziert werden. Im Gegensatz zu 
früheren Untersuchungen, die sich hauptsächlich auf intronische Varianten konzentrierten, 
wurde im Rahmen dieser Promotion eine genomweite exombasierte Fall-Kontroll-Studie 
durchgeführt. DNA-Proben von mehr als 1200 deutschen LLI, darunter 599 Hundertjährige 
(≥100 Jahre), und etwa 6900 jüngeren Kontrollen wurden für einzelvarianten- und genbasierte 
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Assoziationsanalysen verwendet. So konnten zwei neue Kandidatengene für Langlebigkeit 
identifiziert werden, Fructosamin-3-Kinase-related protein (FN3KP) und Phosphoglykolat-
Phosphatase (PGP). FN3KP wirkt der Glykierung von Proteinen entgegen, während PGP über 
die Kontrolle des Glycerin-3-Phosphatspiegels sowohl den Glukose- als auch den 
Fettstoffwechsel beeinflusst. Angesichts dieser biologischen Funktionen erscheinen die 
Langlebigkeitsassoziationen der beiden Gene sehr plausibel. 
 
Kapitel 3 - Das Darmmikrobiom (engl. gut microbiome, GM) hat in den letzten Jahren 
zunehmend an Bedeutung in der Alterungs- und Langlebigkeitsforschung gewonnen. Im 
Rahmen der Promotion wurde eine 16S rRNA-Mikrobiomstudie mit 1301 Stuhlproben von 
gesunden Personen (Altersbereich: 19-104 Jahre) aus drei verschiedenen Kohorten 
durchgeführt. Untersucht wurden potentielle Assoziationen zwischen GM-Zusammensetzung, 
Wirtsgenetik und Umweltfaktoren während des Alterns. Die GM-Zusammensetzung änderte 
sich mit zunehmendem Alter, insbesondere in Richtung einer Zunahme opportunistisch 
pathogener Bakterien, die ein entzündliches Umfeld im Darm erzeugen können. Das Alter per 
se erklärte lediglich ~1% der interindividuellen Variation, während anthropometrische 
Messungen, genetischer Hintergrund und Ernährungsmuster der Probanden zusammen 20% 
erklärten. Auffällig war die deutliche Stratifizierung der GM-Population in vier Enterotypen-
ähnliche Cluster, die mit verschiedenen Ernährungsmustern assoziiert waren. Erst die Korrektur 
für diese Cluster ermöglichte die Vergleichbarkeit der Ergebnisse aus den verschiedenen 
Kohorten. Darüber hinaus zeigten LLI ein spezifisches GM-Muster, das mit zuvor 
veröffentlichten Berichten größtenteils übereinstimmt. 
 
Die vorliegende Doktorarbeit zeigt auf, wie mittels bioinformatischer Expertise und 
Methodenentwicklung die Komplexität der Phänotypen Altern und Langlebigkeit angegangen 
werden kann. Angesichts des bisher begrenzten Forschungsstandes ist insbesondere die 
Entdeckung der neuen Kandidaten-Loci, die die Datengrundlage zur Langlebigkeit erweitern, 
eine zentrale Forschungsleistung. 
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